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/ 1036 13 Is Echocardiography Necessary in 
Anorexigen-Exposed Obese Patients Without a 
Murmur 
Carlos A. Roldan, Edward A. Gill, Heidi M. Conklin, Bruce K. Shively. 
University of New Mexico, Albuquerque, New Mexico; Oregon Health 
Sciences University, Portland, Oregon, USA 
Background: Currently guidelines state that, if a murmur is not detected in a 
patient (pt) exposed to anorexigens, then echo-Doppler may not be indicated. 
However, the diagnostic accuracy of cardiac auscultation for the detection of 
anorexigen valvulopathy is not known and may be low. 
Methods: Echo-Doppler and auscultation were performed <I month 
apart in 412 obese pts: 223 exposed to dexfenfluramine (D) and 189 matched 
controls (C). Exams were performed by board certified internists. Valvulopa- 
thy according to FDA criteria was defined as moderate or greater MR or mild 
or greater AR (FDA-R). Any regurgitation (Any-R) was defined as mild or 
greater MR or AR. 
Results: Pts mean age was 50; body mass index was 35 and 81% were 
female. Duration of D was 6.9 months. FDA-R was present in 7.6% of D pts 
and 2.1% of C (p = 0.01). Any-R was present in 13.0% of D and 7.4% of C (p 
= 0.06). A murmur was heard in 13.9% of D and 10.6% of C. The presence of 
a murmur was not related to FDA-R (p = 0.16) but a trend was observed for 
Any-R (p = 0.07). A murmur was significantly related to mild AR (p < 0.03) 
but not to mild MR (p = 0.19). The sensitivity (SENS) of a murmur for FDA-R 
and Any-R was low, but specificity (SPEC) was high. Because most pts had 
neither regurgitation nor a murmur, the negative predictive value (NPV) of a 
murmur was very high, while its positive predictive value (PPV) was low. 
SENS SPEC PPV NPV 
FDA-R 0.23 0.88 0.10 0.96 
ABNL-R 0.21 0.89 0.18 0.91 
Conclusion: These results suggest that, despite the low sensitivity of 
auscultation, anorexigen-exposed pts without a murmur have a very low 
probability of valvulopathy and do not warrant echo-Doppler. 
1036-l 4 Is Routine Screening of High School Athletes 
Cost Effective? 
Mahesh Amin, Joseph S. Schwartz, Kevin J. Ferrick. Morton P/ant Mease 
Heath System and Montefiore Medical Center, USA 
Background: Sudden Cardiac Death (SCD) in athletes can be caused by 
hypertrophic obstructive cardiomyopathy (HOCM), congenital aortic steno- 
sis (AS), coronary artery anomalies, and Wolff-Parkinson-White Syndrome 
(WPW). Echocardiography (Echo) and electrocardiography (ECG) are diag- 
nostic tests which can easily identify 3 of these abnormalities. We sought to 
assess the cost of routinely performing these tests to identify the high risk 
student athlete. 
Methods: Echo and ECG machines were donated by the Morton Plant 
Mease Health System to screen 1303 high school student athletes in North 
Pinellas County from 1994 to 1999. Evaluations were performed by hospital 
staff prior to the start of each semester on a voluntary basis. Studies were 
reviewed by 11 non-invasive cardiologists. 
Results: Thirty six percent of the high school athletes were screened. 
The average age of the population was 15.5 years and 66% were male. 
Blood pressure greater than 140/90 was found in 4% of the students. The 
cost per student tested was $900. Tables 1 and 2 identify the abnormalities 
found by Echo and ECG. 
Table 1. Echocardiographic Abnormalities 
Abnormality MR TR Al PI HOCM AS MVP LVH ASDiPFO 
#in Male 77 43 12 43 0 0 19 2 3 
#in Female 41 26 1 8 0 0 23 1 0 
Table 2. ElectrocardiographicAbnormalities 
Abnormality Conduction WPW Rhythm Repolarization Other 
# in Male 10 0 7 7 3 
# in Female 2 1 1 9 1 
Conclusion: There were no SCD amongst the athletes in North Pinellas 
County from 1994 to 1999. One student was found to have Wolf-Parkinson- 
White syndrome. Thus, $117,200 would have been required to identify one 
high risk athelete. Although other abnormalities were identified, they are not 
known to cause SCD. The extent and severity of these abnormalities was 
unexpected and the clinical relevance of these findings will require further 
study. 
m 1036 15 Economics of Systematic Management Care for Anticoagulation Therapy Versus Routine Medical 
Care 
Paul M. Campbell, Paul W. Radensky, Charles R. Denham, Alan 
K. Jacobson. Premier lnnovafion Institute, Washington, DC; Loma Linda VA 
Medical Center, Loma Linda, CA, USA 
Background: A comprehensive analysis evaluated the economics of sys- 
tematic management versus routine medical care for anticoagulation therapy 
in patients with atrial fibrillation. 
Methods: Cost estimates for medication (wadarin), medication monitor- 
ing, and hospitalization and follow-up for anticoagulation-related adverse 
events (thromboembolism and major hemorrhage) were derived from aver- 
age wholesale prices (warfarin), the Medicare fee schedule, and hospital and 
outpatient cost data reported in the literature. Drug costs were assumed equal 
under both management strategies. Other costs varied with management ap- 
proach. Among 53 published reports identified for structured abstraction, 15 
reported incidence of adverse events and duration of clinical follow-up, and 
had a minimum of 6 months patient follow-up. Adverse event rates were 
calculated by dividing the number of events in each study by the number of 
patients and the average length of follow-up. Pooled estimates of event rates 
were determined by weighting each study by number of subjects in the study. 
Results: The incidence of adverse events under systematic management 
was lower than routine medical care (events per 1000 patients per year: 
6.6 vs. 53.8, thromboembolism; 15.8 vs. 56.5, hemorrhage, systematic vs. 
routine care, respectively). 
Cost per year per 1000 atrial fibrillation patients 
Cost Component 
Drug therapy 
Drug monitoring 
Adverse events/hospital costs 
- Thromboembolism 
- Hemorrhage 
Total costs 
Systematic Care Routine Care 
$250,000 $250,000 
$310,000 $70,000 
$110,000 $880,000 
$180,000 $650,000 
$850,000 $1,850,000 
Conclusion: Despite increased drug monitoring costs, systematic man- 
agement results in more than a 50% reduction in the total cost of anticoag 
ulation therapy and associated major adverse events compared to routine 
medical care. 
/ 1036-l 6 1 Does Every Patient Need a Comprehensive Echo 
Study? Feasibility of Using “Limited” Imaging for 
Cost-Effective Echo Referral 
Bruce J. Kimura, Casey L. Willis, Anthony N. DeMaria. Scripps Mercy 
Hospital, and the University of California, San Diego, CA, USA 
A “limited echo” (LE) exam has the potential to yield accurate diagnosis at 
substantial cost savings. However, it remains uncertain as to how often and 
in which patients an LE is feasible. Therefore, we compared the accuracy 
and cost effectiveness of LE to full echo (FE) in 154 pts, 74 inpts and 79 
outpts, referred for echo for standard indications. Data were further analyzed 
for pt age 2 or <65 y. The LE exam, defined as gray-scale and color-Doppler 
recording in only the parastemal long-axis view, was reviewed separately for 
the presence of significant abnormalities and later compared to findings on 
FE. Assuming that a normal LE would negate the need for FE, we tabulated 
the number of FEs that would be eliminated (ELIM) and the number of 
abnormal cases that would be missed (MIS) by performing only LE imaging, 
and calculated a cost-effectiveness ratio as CER = ELIM/MIS. 
Results: Significant abnormalities were seen on 35/74 (47%) outpt vs 
55/79 (70%) inpt FEs and in 33/57 (58%) < 65 y vs 67/96 (70%) p 65 y (p 
< 0.05). Sensitivity, specificity, negative and positive predictive values, and 
accuracy, for LE in detecting an abnormal FE were 77%, 77%, 75%, 79% 
and 77% for outpts and 80%, 63%, 83%, 58%, and 75% for inpts (p = NS). 
The proportion of “normal” studies and ELIM were larger (p < 0.05) in the 
Outpt x 65 y group: 
Outot < 65” Outet > 65 v InDt < 65” lmt > 65” 
FE “normal” 25/36 (69%) 14138 (37%) 9121 (43%) 15/58 (26%) 
ELIM Z/36 (69%) 13138 (34%) 1 O/21 (48%) 15158 (26%) 
MIS 4136 (11%) 4/38 (11%) 3/21 (14%) 8158 (14%) 
CER (ELIMIMIS) 6.3 3.1 3.4 1.9 
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Error analysis demonstrated that IO/19 MIS were solely due to incidental 
findings, 9/i 9 MIS would have been avoided with use of M-mode data, and 
all 4 MIS in Outpts < 65 y were of minimal severity. 
Conclusions: The accuracy and cost effectiveness of LE is related to 
in/outpt status and pt age. LE is most cost effective in the outpt setting on 
pts < 65 y, where it can result in a 70% reduction in referral for full echo. 
Further research is needed to evaluate the incidence and clinical impact of 
false negative LE studies. 
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1002-I 67 Regional Left Ventricular Function by 
Angiography: What is Normal and What is Not? 
Classification by Computer-Assisted 
Discriminant Analysis 
Thomas C. Gerber, Sue Weston, Paula Britson, John F. Bresnahan, David 
R. Holmes Jr, Robert S. Schwartz. Mayo Clinic and Foundation, Rochester 
MN, USA 
Background: Qualitative assessment of angiographic left ventricular (LV) 
regional wall motion (RWM) is highly subjective, and accurate identification 
of myocardial target areas for new angiogenic therapies will require a new 
quantitative approach. This study examined whether “normal” or “abnormal” 
myocardial segments on LV angiograms (LVA’s) can be identified semi-auto- 
matically by discriminant analysis. 
Methods: RWM was measured with the “centerline” method in right 
anterior oblique (RAO) views of 141 normal (atypical chest pain, normal 
coronaries, no risk factors) and 155 abnormal LVA’s. The LVA’s were globally 
classified by discriminant analysis (classifiers: all 100 chords, or 12 or 7 
principal components [PC’s] of RWM). 
Results: (Algorithm derived from cross-validation) see Graph. To localize 
abnormal segments, the contour of abnormal LVA’s was divided into 5 seg- 
ments of 20 chords each. Identifying segments containing ~5 chords with 
RWM > 2 standard deviations below normal showed 68% agreement with 
infarct localization by infarct-related artery. 
SensLulty specimty Accwacy 
Conclusions: 1. Abnormal myocardial segments on RAO LVA’s can be 
accurately and reliably identified by a semi-automatic discriminant analysis 
computer algorithm. 2. Use of all available classifiers is not necessary. 3. 
These results may be improved by use of a neural network. 4. New myocardial 
revascularization approaches will likely be aided bythis quantitative approach 
to LV RMW analysis. 
4:12 p.m. 
1 qO2-168 Comparison of Seven Methods of Calculating 
Plaque Volume From lntracoronary Ultrasound 
Cross-Sections, Using a Monte Carlo Simulation 
of Position Errors 
David T. Linker, Linda R. Bossert, Stephanie G. Cooper, Joseph 
W. Chambers, Douglas K. Stewart, B. Greg Brown. Division of Cardiology, 
University of Washington, Seattle, WA, USA 
Background: lntracoronaty ultrasound measurement of plaque volume al- 
lows determination of differences in plaque inapparent on angiography. The 
most accurate and robust method for combining cross-sectional plaque ar- 
eas into a volume calculation is not clear, especially given the known and 
unavoidable errors in longitudinal position due to cardiac motion. 
Methods: An intracoronary ultrasound catheter (30 MHz, 2.9 Fr, CVIS) 
was used for a motorized pullback at 0.5 mm/s of in a non-stenotic vessel 
in subjects in a trial of plaque regression with lipid-lowering therapy, and 
the images were recorded on video tape. Thirty-one such pullbacks were 
digitized using a video digitizer (Fuse, Aurora Designs) in a Macintosh G3 
computer, and custom macros developed for NIH Image version 1.6, which 
controlled the video recorder to allow digitization of every third flame. This 
meant that the inter-frame distance was 0.05 mm. A lesion or area was 
identified and the adventitia-medial border and blood-plaque borders traced 
on images that were roughly equally spaced, but chosen for optimal definition. 
The frame number and area calculations were written to a file, which was 
used for subsequent calculations. Plaque volume was calculated using the 
method of disks, with Simpson’s rule as the last integration step, modified for 
irregularly spaced data. This was compared to the results of 1000 calculations 
using the same data, with introduced random errors of position, with a 
Gaussian distribution and standard deviation of 0.63 mm. Seven algorithms 
were tested, based on an average plaque area (AVE), the maximum plaque 
area (MAX), trapezoidal rule (TR), simplified trapezoidal rule (sTR), simplified 
Simpson’s nile (sSIM), segmented Simpson’s rule (sgSIM), or Simpson’s rule 
for irregularly spaced data (irSIM). The mean of 1000 trials was compared to 
the baseline volume for data without positional errors. 
Results: The simplified Simpson’s method, which substitutes equal spac- 
ing for the actual spacing, resulted in the minimum mean deviation, and best 
correlation, even when there were random errors of position (table). 
AVE MAX TR STR sSlM sgSlM irSlM 
Cow. Coeff. 0.985 0.965 0.990 0.985 0.998 0.996 0.616 
Mean Dev. 4.94’ 14.17* -3.17’ -5.03’ 0.998’ 2.63* 10.75? 
‘p < 0.001, ‘p = 0.014 
Conclusions: We conclude that the simplified Simpson’s formula is the 
most accurate method when there are unavoidable errors of longitudinal 
position of this magnitude. 
4:24 D.m. 
1002-I 69 Assessment of Regional Cardiac Function From 
Taaaed MRI Usina Harmonic Phase (HARPI 
SoKware - 
Nael F. Osman, Jerome Garot’ , Jerry L. Prince. Electrical and Compufer 
Engineering, Johns Hopkins University; ’ Cardiology: Johns Hopkins School 
of Medicine, Baltimore, Maryland, USA 
Background: Tagged MRI uses a special pulse sequence to non-invasively 
impose temporary features inside the heart muscle. When imaged, these 
features appear as multiple lines that bend due to the motion of the heart 
during systole. These lines, called tags, have been used to quantify the 
motion of the heart. The techniques that have been developed for motion 
quantification, however, are slow and require human intervention, which has 
made the clinical application of tagged MRI difficult. 
Methods: We present new software to compute cardiac motion from 
tagged images. The software uses harmonic phase (HARP) MRI, which 
is a new method developed by our group. HARP uses Fourier filtering to 
extract specific regions in the spectrum of the tagged images, producing 
complex images whose phase values are directly related to the motion. 
These harmonic phase images are used to track the motion and measure 
myocardial strain in both Lagrangian and Eulerian sense. The computed 
strains characterize both circumferential shortening and radial thickening 
within octants found at the sub-epicardium, midwall, and sub-endocardium 
of the left ventricle. 
Results: The computations from tagged MR images takes less than 
five minutes on a Pentium II, 366-MHz workstation to produce the final 
measurements. Maps of the circumferential shortening and radial thickening 
are produced. The angle between the maximum thickening and the radial 
direction is presented as a map that is sensitive to motion abnormalities. The 
transient motion between different instants of time is presented as velocity 
fields. Quantitative measurements of the strain components are produced 
during the deformation and presented as plots with time for different regions 
in the LV. 
Conclusion: The HARP analysis software is a valuable tool for determin- 
ing the regional function of the heart from tagged MR images of the heart. 
Because minimal human intervention is required and rapid computations are 
used, the time between acquiring the images and producing a quantitative 
result is less than five minutes on a personal computer, enabling clinical 
application of tagged MR images. 
JACK February 2000 
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Computer-Assisted Endocardial Border 
Detection: Quantitation of Volumes From 
Transthoracic Three-Dimensional 
Echocardiographic Images 
John A. Mondelli, Richard D. VanderLeest, Silvia Di Luzio, Ashwin Nagaraj, 
Bonnie J. Kane, Alka Nagaraj, David D. McPherson, Vera H. Rigolin, Edwin 
L. Dove. Northwestern University Medical School, Chicago, Illinois; 
University of Iowa, Department of Biomedical Engineering, Iowa City Iowa, 
USA 
Background: Real-time three dimensional echocardiography (3DE) provides 
a novel method to collect a complete volumetric data set within one cardiac 
cycle. Without automated border detection, quantitation of this data would 
be laborious. The purpose of this study was to develop a computer-assisted 
border detection (CABD) algorithm to accurately calculate left ventricular (LV) 
volumes from 3DE data sets. 
Methods: Images and simultaneous electromagnetic flow probe (EMF) 
data were collected in 6 mongrel dogs under multiple hemodynamic con- 
ditions with a Volumetrics transthoracic 3DE system. From the 3DE data 
set the operator selected LV end-systolic and end-diastolic frames. Three 
orthogonal planes were chosen for optimal viewing. The operator identified 
the mid-point of the mitral valve annulus in one long axis plane, the apex of 
the LV in both long axis planes, the endocardial wall at the posterior right 
ventricular insertion site, and the endocardial wall at the opposite side (an- 
terior wall). The computer algorithm then generated the LV chamber passing 
through the fiducial points and the volume was calculated. Left ventricular 
stroke volumes (SV) derived from the CABD were compared to EMF derived 
SV and SV calculated from manual tracing of six apical planes using Tomtec 
Echoview Software. 
Results: Good correlation was noted between SV measured by the CABD 
with EMF and manual tracing over a wide range of volumes. 
Conclusion: This CABD algorithm accurately measures SV over a wide 
range of hemodynamic conditions. Using the massive data sets generated by 
volumetric 3DE, CABD provides accurate online quantitation of LV volumes. 
4:48 p.m. 
1002-l 71 Screening of Main Cardiac Diseases Using the 
Heart Magnetic Field Fingerprints 
Alexander Schirdewan, Daniela Selbig, Andrej Gapelyuk, Boris Tysik, 
Udo Meyerfeldt, Franziska Reinsperger, Andreas Voss, Rainer Dietz. 
Franz-Vohard-HospitaL Humboldt University Berlin, Germany 
Background: The long-term prognosis of patients with chronic heart dis- 
eases depends on the early revealing of underlying cardiac disorder. We 
developed a new computerized approach for screening of cardiac diseases 
based on the analysis of cardiac magnetic field maps (cMFM) recorded at 
rest. 
Methods: We investigated 30 normal subjects and 150 patients suffering 
from most frequent heart diseases: coronary artery disease without previous 
myocardial infarction (CAD, n = 62) hypertension with light to moderate left 
ventricular hypertrophy (Hyp, n = 20) without CAD, dilated (DCM, n = 51) 
and hypertrophic (HCM, n = 17) cardiomyopathy. CMFM were recorded over 
the anterior chest wail using a multichannel SQUID-system. A new nonpara- 
metric discrimination technique was applied for analysis of the cMFM. The 
approach included: principal component analysis of magnetic field parame- 
ters, backward stepwise discriminant analysis for selecting the best set of 
predictors. 
Results: Discrimination between normals and patients with heart dis- 
eases was done with a sensitivity of 96.7% (145/150) and a specificity of 
90% (27/30). Numbers of correct classified subjects for corresponding pa- 
tient groups were respectively: HCM -15/17 pts (88.2%), Hyp -17120 pts 
(85%) DCM -41/51 (80.3%) and CAD -52/62 (83.9%). 
Conclusion: the magnetophysiological mapping with a complex analysis 
of the cMFM is an effective, noncontact, low cost, fast and safe approach 
for early detection of cardiac diseases. Discrimination between different 
cardiac disorders can be improved by increasing number of patients (learning 
groups), selecting more disease-specific parameters of cMFM using further 
subdivision within the cardiac disorders. 
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1003-l 72 Aspirin and the Treatment of Heart Failure in the 
Ya-Ting Chen, Martha J. Radford, Harlan M. Krumholz. We University 
School of Medicine, New Haven, Connecticut, USA 
Background: Most of the heart failure (HF) patients have coronary artery 
disease (CAD). The reluctance to use aspirin for patients with HF derives 
from concerns that it can antagonize the action of angiotensin-converting 
enzyme (ACE) inhibitors and decrease glomerular filtration pressure. Few 
studies have examined the use of aspirin and its association with outcomes 
in HF patients. 
Methods: We conducted a retrospective cohort study using data obtained 
from medical charts and administrative files. Patients were consecutive Medi- 
care beneficiaries 65 years and older who survived a hospitalization for HF 
in 1994-1995 and were admitted to one of the 21 Connecticut acute care 
hospitals. For the current analysis, patients were excluded if they had a 
contraindication to aspirin. The main outcome measures were aspirin pre- 
scription at discharge and survival at one-year after discharge. 
Results: Among 1,777 HF patients in the study sample, 656 (37%) were 
prescribed with aspirin at discharged. Patients were more likely to receive 
aspirin at discharge if they had a prior myocardial infarction, prior bypass 
surgery, presence of chest pain on admission, or prescription of beta-blocker, 
calcium channel blocker, nitrates, or ACE inhibitors at discharge. The pre- 
scribed use of aspirin at discharge was associated with a lower one-year 
mortality (odds ratio [OR] 0.79, 95% confidence interval [Cl] 0.64-0.98) after 
adjustment for baseline differences in demographic, clinical and treatment 
characteristics. This beneficial effect of aspirin on mortality persisted within 
each subgroup of gender, age, diabetes, admission creatinine, and discharge 
prescription of beta-blockers, but was less notable in those who had a normal 
left ventricular ejection fraction (>40%), who did not have documented CAD, 
and who did not receive an ACE inhibitor at discharge. The mortality benefit 
of aspirin was evident for patients treated with ACE inhibitors (OR 0.69; 95% 
Cl 0.52-0.91). 
Conclusion: We identified a significant association between the use of 
aspirin and lower mortality in elderly HF patients. The benefit of aspirin is 
consistent with what would be expected from randomized trials of other 
groups of patients with vascular disease. 
512 p.m. 
1003-i 73 The Kansas City Cardiomyopathy Questionnaire 
Predicts Heart Failure Admissions and Death 
John A. Spertus, C. Patrick Green, Charles B. Porter, Dennis R. Bresnahan. 
University of Missouri-Kansas City/Mid-America Heart Institute, KC, MO, 
USA 
Background/Methods: The Kansas City Cardiomyopathy Questionnaire 
(KCCQ) is a new, 23-item, disease-specific health status measure for pa- 
tients with congestive heart failure (CHF). It has previously been shown to be 
valid, reliable and responsive to clinical change. This study tested its ability 
to predict subsequent death and CHF admissions among 91 patients from 
the initial validation study (mean age 65.3 years; mean EF 24%; 68% male; 
NYHA I = 8, II = 51, Ill = 21, IV = 5). KCCQ scores, demographic data (age, 
gender, race) and markers of disease severity (EF, Charlson index) were 
used in univariate and multivariate logistic regression models. Patients were 
followed for a mean of 390 days (range 246-521). 
542A ABSTRACTS - Special Topics JACC February 2000 
Results: Univariate predictors of death and CHF admission were KCCQ 
symptom, physical and summary domains. In multivariate models, the KCCQ 
Summary Score predicted Death & CHF Admission (RR = 2.7 for score < 
50, p < 0.01). 
Conclusion: The KCCQ is a marker of disease severity and can predict 
deaths and hospitalizations in CHF patients. It can be a valuable tool in 
disease management programs and in risk-adjusting outcomes fpr quality 
assessment purposes. 
524 p.m. 
I 1003 174 Enhancing Implementation of Critical Care Pathways for Heart Failure: Lessons Learned 
From a Multicenter Trial 
Edward F. Philbin, Thomas A. Rocco, Jr., Norman W. Lindenmuth, 
Kathleen Ulrich. Henry Ford Hospital, Detroif, Ml; Unity Health System, 
Rochester, NY USA 
Background: Different forms of care management improve process and 
outcome m the treatment of heart failure (HF). We examine the nagging 
problem of low use of critical care pathways (CCP) by describing those 
factors related to successful implementation of a CCP in the context of a 
controlled clinical trial. 
Methods: In the trial, 5 hospitals actively tried to implement a CCP for 
managing all inpatients with confirmed HF (N = 840). In this repot-l, the clinical 
features of patients who were actually treated with a CCP in these hospitals 
(CCP+, N = 358) are compared with those of patients who were not (CCP-, 
N = 482). 
Results: Among all patients, mean age was 77 years, 52% were women, 
mean ejection fraction (EF) was 34% and mean NYHA class was 3.3. The 
prevalence of CCP use among the 5 hospitals was O%, 16%, 44%, 58% 
and 74%. Compared with CCP-, CCP+ were less often nursing home resi- 
dents and Medicaid-insured. Most medical comorbidities were less prevalent 
among CCP+. CCPc were more likely to have HF as the primary diagnosis, 
a higher NYHA class, radiographic cardiomegaly, be admitted to an ICU, be 
treated by a cardiologist and receive ACE inhibitors. CCP+ also had a lower 
mean creatinine and mean Charlson Comorbidity Index, but a higher mean 
hematocrit (all P < 0.05). Age, sex, race, mean EF and etiology of HF were 
not different (all P z 0.05). All statistically significant predictors of CCP use 
which were derived from logistic regression are shown in the table (OR = 
adjusted odds ratio, Cl = confidence intervals, all P < 0.05). 
Positive predictors OR (95% Cl) Negative predictors OR (95% Cl) 
Hospital E 2.10 (1.27-3.47) Hospital B 0.16 (0.09-0.26) 
HF primary diagnosis 3.47 (1.60-7.53) Lives in nursing home 0.54 (0.33-0.89) 
X-ray cardiomegaly 1.85 (1 .17-2.90) Atrial fibrillation 0.59 (0.39-0.89) 
Admitted to ICU 2.70 (1.63-3.96) Pulmonary comorbidity 0.56 (0.36-0.81) 
Use of ?2 diuretics 2.50 (1.34-4.66) Renal comorbidity 0.57 (0.36490) 
Conclusions: In HF patients treated in the community setting, the use of 
CCP is modest (43%) despite aggressive attempts to implement them. Clini- 
cians appear to be more prone to utilize CCP when HF is the primaty problem 
and more severe, but less likely to do so when medical comorbidities are 
present or the patient resides in a nursing home. After adjustment for patient 
characteristics, hospital site is also predictive, suggesting that institutional 
factors are influential as well. 
536 p.m. 
1003-175 Population-Based Medication Profiling in Heart 
Failure: Treatment Related Outcomes From the 
R.E.A.C.H. Study 
Peter A. McCullough, Edward F. Philbin, Barbara Czerska, John A. Spertus, 
W. Douglas Weaver. Henry Ford Heart and Vascular Institute, Detroit, 
Michigan; The Mid America Heart Institute, Kansas City Missouri, USA 
Background: Previous studies have established the efficacy and safety of 
vasodilators and beta-blockers in the treatment of congestive heart failure 
(CHF). We hypothesized that patterns of care based on pharmaceutical 
usage would translate into population-based outcomes, which could become 
the basis of health-system quality improvement. 
Methods: The REACH study is a prospective cohort study of 26,442 CHF 
patients within the Henry Ford Health System (HFHS) in Detroit, Michigan. 
Pharmacy claims were available for 1995-1998 in 3353 patients within the 
HFHS health maintenance organization with newly diagnosed CHF. 
Results: Baseline characteristics: 50% female, 57% white, 37% African 
American, 6% “other” race. Within one year of diagnosis, the rates of med- 
ication usage were as follows: digoxin 27%, diuretics 57%, beta-blockers 
29%, ACE inhibitors 49%, angiotensin II receptor blockers 4%, hydralazine 
4%, and nitrates 22%. The rate of any form of vasodilator therapy proved 
efficacious by clinical trials (ACE, ATRB, NIT + HYD) was 52%. Of those not 
on vasodilator therapy (n = 1607), 21% were treated with calcium channel 
blockers, and 31% with some other form of antihypettensive therapy. Mor- 
tality rates were 3% and 8% for those on vasodilator therapy versus not, 
RR = 0.68, (95% Cl 0.61-0.75), p < 0.0001. Likewise, the mortality rates 
were 4% and 6% for those on beta-blockers versus not, RR = 0.88, (95% Cl 
0.82-0.95), p = 0.004. 
Conclusion: In a population of newly diagnosed CHF where access 
to care and prescription benefits are held the same, the largest area for 
improvement in CHF care appears to be use of some form of vasodilator 
therapy proven to reduce mortality in clinical trials. In addition, beta-blockers 
have had a low penetration (29%) compared to other forms of treatment, and 
are another clear opportunity for improvement. 
5:48 p.m. 
1003-I 76 Academic Detailing and Provider Feedback 
Improve Implementation of the Heart Failure 
Guidelines by Primary Care Providers 
Judy Wiles, Prakash C. Deedwania. VACCHCS, Fresno, CA; UCSFSchool 
of Medicine, San Francisco, CA, USA 
Although treatment of HF with digoxin, diuretics, and ACE inhibitors is ef- 
fective in improving clinical outcome, many heart failure patients treated by 
primary care providers (PCP) do not receive adequate regimens. Although 
it has been suggested that academic detailing and provider feedback would 
improve adherence to guidelines, little is known about the efficacy of such 
implementation. Accordingly, we evaluated the role of academic detailing 
and provider feedback in implementation of HF guidelines by PCPs, begin- 
ning with initial evaluation of 25 HF patients which showed that only 20% 
of patients had LV function evaluation, 50% had etiology of HF, 68% were 
on ACE inhibitors, 33% were counselled about diet and smoking cessation, 
and only 17% were given advice about regular low-level aerobic activity. 
After initial evaluation, several educational sessions were held about the im- 
portance and benefits of guideline implementation; each PCP was provided 
charts of guidelines. Subsequently, a patient/provider contract emphasizing 
the need for guideline adherence was developed. Each PCP’s performance 
was tracked and feedback regarding performance was provided on a regular 
basis. Nine months following academic detailing and provider feedback, sig- 
nificant improvement was noted in most areas of guideline implementation. 
A review of 88 patients during the follow-up period showed that 74% had LV 
function data, 85% had etiology of HF, 90% were on ACE inhibitors, 55% 
received dietary advice, 45% were asked to stop smoking, and 35% were 
told the benefits of regular exercise. 
Conclusion: These results suggest that academic detailing and provider 
feedback can improve implementation of the practice guidelines in the man- 
agement of patients with HF by primary care providers. 
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1058-l 3 Identification of High Risk Patients With Coronary 
Artery Disease 
Linda K. Shaw, Kerry L. Lee, Charles F. Bethea, Eric D. Peterson. Duke 
Clinical Research Instifufe, Durham, NC; Baptist Medical Center, Oklahoma 
City OK, USA 
Background: It is important to identify patients who are likely to have severe 
coronary artery disease (CAD), defined as 3 vessel or left main disease, 
as these patients are at high risk and may benefit from revascularization 
therapy. 
Methods: We developed and validated a new severe CAD clinical pre- 
diction model in a contemporary patient population. After excluding patients 
with prior revascularization, 11,795 symptomatic patients, age p25 under- 
going catheterization at Duke Medical Center 1990-1997 were included. 
Multivariable logistic regression modeling was used to determine significant 
independent clinical and ECG predictors. A sample of 4,911 patients under- 
going catheterization at Baptist Medical Center in Oklahoma (OK) was used 
for external validation. 
Results: The proportion of patients with severe CAD was similar in the two 
populations, 21 .I% (Duke) vs 20.5% (OK). Significant independent predictors 
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of severe CAD (p < 0.001) included: age, male gender, race (Caucasian), 
hypertension, diabetes, vascular disease, typical angina, symptom duration, 
history of MI, CHF symptoms, 53, and ECG (Qwaves, STT changes). Dis- 
criminatory ability of the model, based on ROC areas, was high in both the 
development and validation samples, 0.76 (Duke) vs 0.77 (OK). Calibration 
of the model was also excellent in the validation sample (Observed propor- 
tians and model predictions of severe CAD across deciles of risk were nearly 
identical). 
Conclusions: This study shows that a reliable and discriminating risk 
model for predicting the likelihood of severe CAD can be developed using 
presenting ECG and clinical characteristics and validly applied to an indepen- 
dent patient population. Diagnostic models such as this provide useful tools 
to risk stratify patients, thereby improving the quality and cost effectiveness 
of health care. 
1058-14 Effect of End-of-month Admission on Length of 
Stay for Acute Myocardial Infarction Patients 
James P. Smith, Rajendra H. Mehta, Sugata K. Das, Thomas T. Tsai, Dean 
J. Karavite, Pamela L. Russman, David Bruckman, Kim A. Eagle. The 
University of Michigan Heart Care Program, Ann Arbor, Michigan, USA 
Background: Hospital length of stay (LOS) is an important factor in health 
care cost. Many variables have been shown to influence LOS in acute Ml 
(AMI) patients (pts), but previous studies have not addressed the effect of the 
discontinuity of care that occurs as faculty and housestaff rotate off-service. 
Methods: Retrospective analysis was performed using a database of 905 
patients diagnosed with AMI, cared for on an inpatient cardiology service 
from 1995-l 998, and discharged alive. Univariate (chi-square) analyses and 
multivariate modeling determined variables that influenced hospital LOS (log 
transformed). Because faculty and housestafl rotate services on the first 
of each month at our institution, pts admitted on the last four days of the 
month and discharged after the first of the subsequent month were denoted 
“end-of-month (EOM)” pts; all others were considered “mid-month” pts. 
Results: 780 (86.2%) were admitted mid-month and 125 (13.8%) at 
EOM. Mean LOS were 7.2 (95% C.I. [6.7,7.6]) days for mid-month pts and 
8.8 [7.3,10.2] days for EOM pts (p = 0.04). Marginal correlates (p x 0.20) of 
LOS including admission route (direct, via ER, transfer), risk factors, medical 
history (h/o), in-house complications (cpx), and procedures were included in 
modeling LOS. Independent predictors were pts age; EOM status; h/o PVOD; 
cpx of CHF, coronary ischemia, or renal disease; and procedures including 
intubation, PA catheter use, IABP, and CABG (all p < 0.01). A second model 
was generated with 474 pts transferred to the Cardiology service from outside 
hospitals or other in-hospital teams, 71 (15%) being EOM pts. This model of 
LOS revealed as predictors: age; EOM status; h/o diabetes, PVOD, or CHF; 
cpx of CHF, renal failure, or cardiac arrest; intubation, PA catheter, IABP, and 
CABG (all p < 0.04). This model accounted for 42% of the LOS variation 
among transfer pts (similar to model with direct pts). EOM status was not an 
independent predictor of LOS in a third model that excluded transfer pts. 
Conclusion: (1) Admission during the last four days of the month and 
discharge after the switch of inpatient teams is an independent predictor of 
LOS. (2) This effect appears to be greatest among pts transferred to the 
service soon before the staff rotates. (3) Transferred pts may have more 
severe disease and comorbidities, making it more difficult for a new impatient 
team to efficiently assume care. 
1058-I 5 Sex-based Differences in One-Year Mortality 
Following Cardiac Catheterization: Observations 
From a L%ge Outcome-focused Database From 
the Province of Alberta, Canada 
Michael J. Curtis. On behalf ofAPPROACH Investigators, University of 
Calgary Alberta and University of Alberta, Edmonton, Alberta, Canada 
Background: Cardiovascular disease is recognized as the leading cause of 
death among women. Recent emphasis has been directed to post-MI mor- 
tality. Whether these differences exist in a broader coronary artery disease 
population remains unclear. 
Methods: Between January 1995 and December 1997, 14,173 patients 
(32% females) were registered at the time of diagnostic cardiac catheteriza- 
tion, in the inception-cohort APPROACH Project. Patients were divided into 
low risk (patients with one and two-vessel disease not involving the proximal 
left anterior descending) and high risk (patients with two-vessel disease with 
proximal left anterior descending involvement, three-vessel and left main 
disease) anatomical subgroups. Initial treatment strategies and one-year 
mortality rates were evaluated. Mortality rates were risk adjusted for baseline 
variable differences by multiple logistic regression analysis. 
Results: The table below reflects the initial Medicine-only, coronary 
artery bypass grafting (CABG), and percutaneous coronary intervention (PCI) 
strategies by risk and gender and one-year risk-ad usted mortality. 
Medicine Low Risk 
”  Adjusted Mortality p value 
Males Females 
2976 2.3 2.3 “S 
CABG 
PCI 
High Risk 
Low Risk 
High Risk 
Low Risk 
High Risk 
2217 8.6 12.6 0.0030 
685 4.0 4.0 “S 
3009 6.6 9.6 0.0072 
3593 2.1 1.8 ns 
1693 5.8 9.1 0.0365 
Conclusion: In an anatomically-defined low risk coronary artery disease 
population there was no difference in one-year mortality for males and fe- 
males for all treatment strategies. However, in the high risk population males 
have a significant mortality advantage in all treatment strategies. 
L---i-l 1058 16 Predictors of Cause-Specific Hospital 
Readmission in Men and Women With Congestive 
Heart Failure 
Zaruhi V. Babayan, Robert L. McNamara, Edward K. Kasper, Haroutune 
K. Armenian, Neil Ft. Powe, Kenneth L. Baughman, Joao A.C. Lima. Johns 
Hopkins Medical Insfitutions, Baltimore, Mary/and, USA 
Background: Congestive heart failure (CHF) has emerged as the leading 
cause of hospitalizations in the U.S. We examined the independent role of 
ischemic etiology of CHF in predicting cause-specific hospital readmissions 
and evaluated a possible gender-differential in this regard. Predictive models 
for cause-specific readmissions were developed for men and women. 
Methods: We conducted a non-concurrent prospective cohort study of 
493 consecutive patients admitted through the emergency department of a 
large metropolitan hospital in 1996-97 with a principal diagnosis of CHF. 
Mean follow-up was 14.9 f 11.5 months. lschemic CHF was defined as 
documented history of Ml, CABG or PTCA, or ~70% coronary stenosis. LV 
function was assessed by echo. Specific cause of hospital readmission was 
classified as CHF, cardiovascular disease (CVD) other than CHF, and other 
non-CVD. Analyses were stratified by gender. 
Results: Allcause readmissions were frequent: 127 (54.0%) men and 
140 (54.3%) women were readmitted within a year. 62.2% of these read- 
missions occurred within 3 months of discharge. lschemic CHF was a sig- 
nificant predictor of all-cause readmission: age- and LV function- adjusted 
Cox Hazard Ratio 1.49 (1.16-I .91). Women with ischemic CHF had greater 
risk for all-cause readmission compared to women with non-ischemic CHF: 
1.83 (1.30-2.57); this was not seen in men: 1.29 (0.89-l .88). In analysis of 
cause-specific readmissions, ischemic etiology was not associated with in- 
creased risk of readmission for CHF. Readmission for CHF was predicted by 
LV dysfunction: 3.18 (1.83-5.54). LV dysfunction also predicted readmission 
for CVD other than CHF, regardless of gender or etiology: 2.02 (1 .I 7-3.50). 
Moreover, readmission for CVD other than CHF was predicted by ischemic 
etiology in women: HR = 3.83 (1.97-7.47) but not in men: 1.35 (0.72-2.54). 
Conclusions: lschemic etiology of CHF is a significant predictor of all- 
cause hospital readmission in women but not in men. Importantly, the effect of 
ischemic CHF on all-cause readmission is mediated through readmission for 
CVD other than CHF. Readmission for CHF is predicted by LV dysfunction in 
both genders. CHF patients can be accurately risk stratified for cause-specific 
hospital readmission with routinely obtained clinical information. 
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I 1081 13 Biases in the Evaluation of Risk Associated With Cigarette Smoking Following PTCA 
William S. Weintraub, Elizabeth M. Mahoney. Emory University: Atlanta, GA, 
USA 
The risk associated with cigarette smoking (S) following PTCA was studied in 
16,623 patients who underwent PTCA from 1990-1998 (3383 current, 7844 
former, 5381 never S). Unadjusted S-year survival was 0.86 in current, 0.83 
in former, and 0.84 in never S; however, the effect of smoking on survival is 
confounded by several other known risk factors. S were younger, less often 
female, and had less HTN, diabetes (DM), and fewer prior MIS (see table). 
The best fitting survival model included S, age, year of procedure, LVEF, 
DM, CHF, HTN, number of vessels diseased (#VD), gender, prior CABG, 
prior PTCA, urgenuemerg., Q-wave MI, and four interactions (SYVD, S*DM, 
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S*gender, DM*age). The c-index from model bootstrap validation was 0.75. 
The .S*DM interaction was highly significant. Non-DM current and past S had 
an increased risk relative to non-S; however, a lower risk was found for DM 
current S vs both DM nonS (OR: 0.65 [0.44-0.941) and DM past S (OR: 0.59 
[0.49-9.87]). These results likely reflect a harvest effect resulting from earlier 
deaths among diabetic S and/or avoidance of PTCA in diabetic S. 
were associated with /LOS post-CABG. The Ra for the PICA and CABG 
models was only 0.11 and 0.14, respectively. When complications (CM) were 
added to the models the R* increased to 0.27 and 0.25 (validated using 
bootstrap). Post-procedural CM including CABG, AMI, and renal, vascular 
and bleeding CM were all highly predictive of TLOS post-PTCA, while AMI, 
mechanical support, blood products required, and neurologic and renal CM 
were associated with TLOS post-CABG. In-hospital death was associated 
Age 
Female 
Hypertension 
Prior MI 
Diabetes 
Multi-vessel Disease 
current F0rtrler N&W p-WlUe 
55&11 fi2*11 65 zb 11 <0.0001 
25.2% 16.2% 42.3% <0.0001 
49.2% 54.7% 59.5% <0.0001 
56.8% 50.3% 43.9% <0.0001 
16.4% 22.2% 26.2% <0.0001 
47.2% 58.0% 54.6 <0.0001 
Conclusion: Examination of population based risk factors in patients with 
established disease may suffer from biases making the determination of risk 
difficult. 
1081-l 4 Quality of Life After Coronary Artery Bypass Graft 
Surgery: Predicting Mental Health Status 
John S. Rumsfeld, Frederick A. Masoudi, Samantha MaWhinney, Karl 
E. Hammermeister. Denver VA Medical Center/University of Colorado 
Health Sciences Center, Denver, Colorado; Martin McCarthy Northwestern 
University, Chicago, Illinois, USA 
Background: Risk factors for mortality after coronary artery bypass graft 
(CABG) surgery have been established. However, much less is known about 
the determinants of post-operative Quality of Life (QOL). Mental health sta- 
tus is a major domain of QOL, and there is growing evidence of a link 
between mental health and coronary artery disease. We sought to identify 
the predictors of mental health status 6 months following CABG surgery. 
Methods: All patients enrolled in VA Cooperative Study in Health Services 
#5 (Processes, Structures, and Outcomes of Care in Cardiac Surgery) with 
both a pre-operative and 6-month post-operative Short Form 36 (SF-36) 
health status survey were studied (n = 1,973). The outcome variable was the 
Mental Component Summary (MCS) score from the post-operative SF-36. 
Candidate predictor variables included both traditional clinical risk variables 
and baseline SF-36 summary scores. We employed multiple linear regression 
to identify the predictors of the B-month post-operative MCS score. 
Results: Significant (p < 0.05) predictors of lower 6-month post-operative 
MCS score, in order of magnitude, were history of psychiatric disease, lower 
preoperative MCS score, chronic obstructive pulmonary disease, current 
smoking, higher NYHA functional class, increasing age, and lower pre-oper- 
ative Physical Component Summary (PCS) score from the baseline SF-36. 
Conclusion: Pre-operative mental and physical health status are both 
independent predictors of 6-month mental health status following CABG 
surgery. Furthermore, a history of psychiatric disease, not previously associ- 
ated with post-CABG outcomes, is predictive of mental health status following 
CABG surgery independent of pre-operative MCS score. Therefore, in addi- 
tion to traditional clinical risk variables, clinicians should consider measures 
of preoperative quality of life and history of psychiatric disease when coun- 
seling patients with regard to mental health status outcomes following CABG 
surgery. 
1 1081-I 5 1 Factors Associated With Increased Length of Stay 
Following PTCA and CABG in 1998: Results From 
the National Cardiovascular Network (NCN) 
Trevor D. Thompson, Elizabeth M. Mahoney, Emir Veledar, Haitao Chu, Eric 
D. Peterson, William S. Weintraub. National Cardiovascular Network (NCN) 
and Emory University Atlanta, GA, USA 
Background: Length of Stay (LOS) following revascularization is a primary 
determinant of total hospital cost. 
Methods: Linear regression was used to identify factors associated with 
post-procedure LOS for 12,847 PTCA and 7,810 CABG procedures from 
i/98 to 6/98 at 19 NCN sites. Normal scores, created from ranked LOS, were 
used as the outcome variable in order to meet normality assumptions. 
Results: Median (mean, 25-75%) LOS (days) was 1 (2.1, 1-2) for PTCA 
and 6 (7.3,4-8) for CABG. In models including only clinical and demographic 
variables, fage, CHF, renal insufficiency, and urgency were significantly as- 
sociated with TLOS for both PTCA and CABG patients. For PTCA, cere- 
brovascular disease, acute MI, JEF, and JLVEDP were also associated with 
&LOS, and prior PTCA and lefl main stenosis were associated with &LOS. 
For CABG, female gender, black race, diabetes, t# of vessels diseased, 
t# of distal anastomoses, COPD, and mitral incompetence were associated 
with tL0.S. EF and LVEDP each had an effect on post-CABG LOS that was 
non-linear. Unstable angina, prior PTCA, PVD, IMA, and left main disease 
with &LOS in both models. 
Conclusions: There are many factors associated with length of stay fol- 
lowing CABG or PTCA. Procedural complications have the greatest influence 
on LOS; however, even after taking complications into consideration, much 
of the variability in LOS remains unexplained. 
L---i- 1081 16 The Influence of the BARI Diabetic Treatment 
Alert on Revascularization Selection Patterns: 
The NCN Results 
Eric D. Peterson, Kevin J. Anstrom, Darren K. McGuire. Duke Clinical 
Research Institute, Durham, NC; The National Cardiovascular Network, 
Atlanta, GA, USA 
Background: In September 1995, the BARI trial issued an NIH Clinical Alert, 
reporting that diabetics with multivessel CAD had improved survival rates if 
treated with CABG vs. PTCA. The impact of the Alert on clinical practice has 
not been well studied. 
Methods: Using the National Cardiovascular Network’s Database, we 
examined trends in treatment selection before and after the Alert among 
diabetic, ‘BARI-eligible’ patients undergoing revascularization. 
Results: There were 11,000 diabetics with 2 or 3VD who underwent PTCA 
or CABG at 13 NCN sites between i/94 and l/98 who met BARI eligibility 
criteria. Their mean age was 64.5 years; 40% were female; and 60% had 
3VD. 48% of diabetics with 2VD and 14% of those with 3VD underwent PTCA 
vs. CABG. 
Time Period % PTCA Use in % PTCA Use in 
Diabetics w/ 2VD Diabetics wi 3VD 
Pre-Alert (i/94-9/95) 48.6% 14.3% 
Post-Alert (1 O/95-/98) 47.5% 13.4% 
D = NS for time trend in PTCA use in both 2VD and 3VD diabetics 
The mode of revascularization for diabetics, however, varied significantly 
among sites (from 25% to 82% PTCA use for 2VD and from 2% to 47% 
PTCA use for 3VD). The BARI Alert had limited impact on individual sites’ 
treatment patterns: 2 sites significantly decreased PTCA use after the Alert, 
3 sites significantly increased use and 8 sites were unchanged. 
Conclusions: Limited community consensus exists regarding the most 
appropriate mode of revascularization for diabetics with multivessel CAD. The 
BARI trial and Alert appear not to have significantly altered these treatment 
choices. 
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L---i- 1501 1 TELEREMEDY: 18 Months Experience With a Telemedicine System for Remote Diagnosis 
Management and Education in Congenital Heart 
Disease 
lgnatios Ikonomidis, Periklis A. Davlouros, Vasilis Thanopoulos, Christos 
Pafitis, George Hahalis, Kostas Evdorides, Dimitris Alexopoulos, Nicholas 
Beratis, Antonis S. Manolis. Cardiology: fatras University Hospital, Greece 
Background: A common problem in hospitals with lack of on site paediatric 
cardiologists is diagnosis of children with Congenital Hear-l Disease (CHD). 
Methods: The last 18 months the cardiologists and paediatricians of 
our hospital communicate with paediatric cardiologists at tertiary Childrens 
Hospitals using a telemedicine program with the acronym TELEREMEDY 
(Remote Diagnosis Management and Education in CHD). The program is 
funded by European Union and connects 5 hospitals in Europe through 
Euro-ISDN (Integrated System Digital Network) lines. The high speed of 
data transmission (64 Kbps x 6 channels) permits the on-line, real-time tele- 
conference. The equipment include a) a personal computer b) a videocamera 
for transmission of picture and sound c) two television sets for projection of 
picture and sound among connected sites with the capacity to transmit real 
time echocardiograms, ECGs and x-rays. 
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Results: Ninety-five children with suspected CHD were examined. Ninety 
had an echocardiogram that confirmed CHD in 53 (59%) acquired heart dis- 
ease in 11 (12%) and normal anatomy in 26 (29%). VSD was diagnosed 
in 16153 (30%) and a complex CHD in another 16 (30%). Twenty-four tele- 
conference sessions were organised. During 17 sessions with the tertiary 
Childrens Hospital, decisions were taken about the optimal treatment plan 
of children with newly diagnosed CHD whereas an immediate transfer to the 
NICU of the tertiary center was decided for 20 cases. Our hospital, as ex- 
pertise center provided consultation and diagnosis on 30 arrhythmia cases. 
During 4 sessions with Royal Brompton Hospital (London), rare CHD cases 
were discussed. The sensitivity and specificity of precordial murmur > i/6 
for predicting CHD in our NICU was 93% and 72% respectively. 
Conclusions: Echocardiography combined with telemedicine applica- 
tions like TELEREMEDY facilitate the timely diagnosis of CHD cases, in 
hospitals with lack of paediatric cardiology unit. The immediate access to 
specialists may alter the morbidity or unnecessary, costly treatment. 
/ 1501-2 1 Transtelephonic Patient Entry of Results From 
Home Prothrombin Time Testing Into a Centralized 
Anticoagulation Clinic Database 
Alan K. Jacobson, Phillip Ng, Norman Peckham, Robed Scott. Loma Linda 
VA Medical Center, Loma Linda, CA; /nterC/in, Loma Linda, CA, USA 
Purpose: Portable monitors to allow patients to perform home testing of the 
prothrombin time (PT) were approved for use by the FDA in the spring of 
1998 and have been under evaluation in our clinic since the spring of 1997. 
These devices improve patient access to testing and a realistic method to 
increase the baseline frequency of testing to once a week. The increased 
number of test results and the decentralized nature of the testing makes it 
difficult to provide ongoing awareness and surveillance of patient test results 
without utilizing a significant amount of staff time. This project is to evaluate 
the effectiveness of an automated method of data entry to provide ongoing 
patient oversight with economical use of staff resources. 
Methods: A proprietary computer system was developed to provide man- 
agement support to the anticoagulation clinic. This system allows clinic pa- 
tients to perform transtelephonic entry of home PT test results into the clinic 
database. In addition to storing the test result in the database, the system 
also prints out a label containing the test results on a printer in the clinic, The 
clinic staff only need to scan the printed labels to determine which patients 
are outside the desired therapeutic range and require staff intervention. All 
patients being trained in home testing are provided basic instruction in the 
use of transtelephonic data entry. 
Results: Currently, 109 of 110 patients performing home PT testing utilize 
transtelephonic data entry as their primary method for reporting results. Cross 
section of the files evaluation demonstrates 82% time in therapeutic range 
(within 0.7 INR units of target INR). 
Discussion: In the typical anticoagulation management setting, the ma- 
jority of the staff time is spent processing routine results. In our system, the 
great majority of results are handled in an automated manner and staff time 
is only utilized in the management and evaluation of out of range results. 
Conclusion: The majority of patients performing home PT testing are able 
to enter their test results into a centralized database utilizing transtelephonic 
enty. The automated handling of test results allows for improved efficiency 
of clinic staff. 
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/ 408-I j Augmentation of Postnatal Neovascularization by 
Transplantation of Cord Blood-Derived Endothelial 
Progenitor Cells 
Toyoaki Murohara, Kazuo Matsui, Tsutomu Imaizumi. Cardiovascular 
Research Institute, Kurume University School of Medicine, Japan 
Postnatal neovascularization has been considered to result exclusively from 
the proliferation, migration and remodeling of fully differentiated endothelial 
cells (ECs). However, peripheral blood of adult species has been shown to 
contain endotheliai progenitor cells (EPCs). We examined whether EPCs 
can be isolated from human cord blood, a rich source for CD34 positive cells, 
and whether transplantation of cord blood-derived EPCs can modulate post- 
natal neovascularization. Mononuclear cells (MNCs) were isolated from cord 
blood (n = 72) by a density-gradient method. During culture on fibronectin, 
attached and spindle-shaped (AT) cells developed from MNCs which created 
numerous cell clusters and cord-like structures. When CD34-positive cells 
were labeled with a green fluorescence dye, and cocultured with non-labeled 
CD36negative cells, all the cell clusters and cord-like structures expressed 
fluorescence suggesting that these structures derived from CD3Cpositive 
cells. AT cells took up Dil-labeled acetylated low-density lipoproteins, re- 
leased nitric oxide and expressed CD31, KDR and factor VIII-related anti- 
gen, characteristic markers for ECs. AT cells thus have EC-like phenotype 
and were defined as EPCs. The fluorescence-labeled EPCs participated in 
the EC capillary network on matrix gel in vitro. Locally transplanted cord 
blood-derived EPCs survived and were incorporated into sites of neovascu- 
larization in the ischemic hindlimb in immunodeficient (F344/N mu/mu) nude 
rats in vivo. Furthermore, serial laser Doppler blood perfusion analysis and 
histological capillary density revealed that transplantation of EPCs quantita- 
tively augmented neovascularization in the ischemic hindlimb. In summary, 
our results suggest that cord blood is a precious source for isolating EPCs, 
and transplantation of cord blood-derived EPCs may potentially be a useful 
strategy for modulation of postnatal neovascularization. 
11:15 a.m. 
1408-2 / Complete Reversal of Fatal Pulmonary Hypertension 
in Rats by a Serine Elastase Inhibitor 
Kyle N. Cowan, Adrian Heilbut, Tilman Humpl, Catherine Lam, Shinya Ito, 
Marlene Rabinovitch. Hospital for Sick Children/University of Toronto, 
Toronto, ON, Canada 
Progressive pulmonary hypertension is associated with increased elastolytic 
activity and enhanced proteinase-dependent deposition of tenascin-C (TN), 
an extracellular matrix (ECM) glycoprotein which supports growth factor- 
dependent proliferation of smooth muscle cells (SMCs). By contrast, inhibi- 
tion of elastase is associated with suppression of TN synthesis, absence of 
SMC proliferation, induction of apoptosis, and regression of hypertrophied 
rat pulmonary arteries (PAS) in organ culture. We now determine whether 
severe pulmonary hypertension (PH), induced in rats 21 days following the 
injection of the toxin monocrotaline (MCT), can be reversed through the oral 
administration of peptidyl trifluoromethyl ketones, either ZD0892 or M249314 
(Zeneca), which inhibit serine elastase activity. One week of treatment docu- 
menting complete inhibition of MCT-induced elastase activity resulted in 92% 
survival vs 39% in untreated rats. Survival was mediated by reduced TN 
deposition and the subsequent suppression of proliferation (-5 fold by prolif- 
erating cell nuclear antigen immunostaining) and induction of SMC apoptosis 
(-10 fold by TUNEL assay), together with resorption of pathogenic ECM, 
specifically increased elastin and TN. This process reversed peripheral PA 
muscularization (-67% by barium-gelatin perfusion morphomety), reduced 
elevated PA pressure (-56% by direct catheterization; treated = -28 mmHg 
vs controls = -44 mmHg; normal = -19 mmHg), and arrested right ventric- 
ular hypertrophy and PA loss. A further week of M249314 treatment resulted 
in normalization of PA pressure (-20 mmHg) and structure with 86% survival 
vs none in controls. Thus elastase inhibitors, through the regression of mus- 
cularized distal vessels by SMC apoptosis and loss of ECM, offer a novel and 
potentially clinically applicable therapeutic approach to treating severe PH. 
11:30 a.m. 
408-3 Nicotine is an Agent of Angiogenesis: Role of Nitric 
Oxide and Prostacyclin 
Christopher Heeschen, Hoai-Ky Ho, James Jang, Shuichiro Kaji, Phil Yang, 
Bob S. Hu, Phil Tsao, John P. Cooke. Stanford University School of 
Medicine, USA 
Background: To investigate the role of nicotine in the stimulation of an- 
giogenesis, we used a disk angiogenesis system and a model of hindlimb 
ischemia. 
Methods: The DAS was subcutaneously implanted in 12-week old C57BU 
6J mice. Some discs were treated with nicotine solution (n = 15; 20 pL; 0.1 
mM) in the presence or absence of either indomethacin (n = 5; 20 pL, 10-s 
M) or L-nitroarginine (n = 5; 20 @L; 10-s M). Discs were harvested after 2 
weeks and the area of fibrovascular growth was measured as an index of 
angiogenesis. In subsequent studies with the hindlimb ischemia model, right 
femoral arteries were excised. Mice were treated with nicotine, epibatidine, 
or saline by daily intramuscular injections into the ischemic hindlimb. Three 
weeks after surgery, angiogenesis was quantified by magnetic resonance 
perfusion imaging as flow index, and by determination of capillary density 
(capillary/myocyte ratio). 
Results: In the DAS, fibrovascular growth was doubled by nicotine (20 
vs. 12 mm*; P f 0.001). This effect was blocked by indomethacin (3.7 mm’) 
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or by L-nitroarginine (7.3 mm*). Capillary density in the model of hindlimb 
ischemia was significantly increased by either nicotine (0.1 pg/kg; 0.48; P = 
0.005) or epibatidine (0.001 @g/kg; 0.56; P < 0.001) as compared to saline 
treated mice (0.29). In contrast, at higher concentrations of nicotine (3.0 
fig/kg), cytotoxicity was observed with reduced numbers of myocytes per 
field and no significant increase for capillaty/myocyte ratio. Concordantly, 
limb blood flow as assessed by MR perfusion was also higher in nicotine 
(0.26; P = 0.031) and epibatidine (0.25; P = 0.004) group as compared to 
saline (0.12). This effect of nicotine on angiogenesis was abrogated by the 
nicotinic receptor antagonist mecamylamine. 
Conclusions: Nicotine stimulates angiogenesis in vivo. The response 
to nicotine is bimodal, with angiogenesis at lower and cytotoxicity at higher 
concentrations, appears to be mediated by the nicotinic receptor and depends 
on products of the cycloxygenase and NO synthase pathways. The observed 
angiogenic effect of nicotine is equivalent to that of other growth factors, and 
may have implications for plaque growth, as well as neoplastic or therapeutic 
angiogenesis. 
11:45 a.m. 
1408-4 1 Changes in Myocardial Blood Volume Over a Wide 
Ranae of Coro-narv Drivina Pressures: Role of 
Capilaries in Auto;egulati& 
D. Elizabeth Le, Ananda R. Jayaweera, Kevin Wei, Matthew P. Coggins, 
Jonathan R. Lindner, Sanjiv Kaul. FACU University of Virginia, 
Charlottesville, !&I, USA 
Background: Capillaries are not known to participate in the regulation of 
coronary blood flow. The principal aim of autoregulation is maintenance 
of normal capillary hydrostatic pressure. We, therefore, hypothesized that 
when the vasomotor capacity of the coronaty arterioles is exhausted at rest, 
capillary blood volume (CapBV) decreases to maintain a normal capillary 
hydrostatic pressure, even at the expense of myocardial oxygen delivery. 
Methods and Results: Fifteen dogs were studied. In Group I (n = 9), 
coronary driving pressure (CDP) was increased above normal by elevating 
the aortic pressure by 20 to 80 mm Hg above baseline over 2-3 stages with 
a phenylephrine infusion. In group II (n = 6), CDP was reduced to 2-3 levels 
below normal using a custom-designed screw-occluder. Myocardial contrast 
echocardiography was performed to measure CapBV fraction (acoustic den- 
sitometric measurements during continuous infusion of microbubbles, nor- 
malized to that of the LV cavity). Coronary blood flow, as well as myocardial 
oxygen demand and consumption (MVO& were also measured. In Group 
I dogs, despite the expected increases in myocardial oxygen demand and 
coronary blood flow with increasing CDP, MVOZ did not demonstrate a pro- 
portionate increase. CapBV fraction progressively decreased from a baseline 
value of 0.68 to 0.028 at very high CDP. In Group II dogs, there was a marked 
decline in MVOz with decreasing CDPs, which was far greater than the de- 
cline in myocardial oxygen demand. CapBV fraction decreased from 0.09 at 
baseline to 0.012 at very low CDP. There was a significant positive correlation 
between MV02 and myocardium blood volume fraction (r = 0.83, p < 0.01). 
Conclusion: Our results demonstrate that capillaries participate in the 
regulation of coronary blood flow. When arteriolar tone is exhausted so 
that coronary blood flow is dependent on CDP, myocardial blood volume 
decreases in order to maintain a constant capillary hydrostatic pressure. The 
regulation of capillary hydrostatic pressure takes precedence over myocardial 
oxygen delivery. These novel findings provide unique new insights into the 
regulation of coronary blood flow. 
Noon 
/ 408 5 Assessment of Global Atrial Fibrillation Organization to Optimize the Timing of Atrial Defibrillation 
Thomas H. Everett, J. Randall Moorman, Lai-Chow Kok, David E. Haines. 
University of Virginia Health System, Charlottesville, Virginia, USA 
We hypothesized that FFTanalysis of a filtered wide bipolar atrial electrogram 
(AEG) predicts the global organization of atrial fibrillation (AF), and should 
vary over time. Timing shocks to periods of high organization of AF should 
improve cardioversion efficacy. 
Methods: AF was induced by rapid atrial pacing IO dogs (27.1 f 3.4 
kg) at 640 bpm for 48-72 hrs. Coil electrodes (1.80 cm2) were placed in the 
left and right atria via transvenous and transeptal approaches. Wide bipolar 
AEGs were digitally filtered and a FFT was performed over a sliding 2 set 
window every 0.5 seconds. The Organizational index (01) was calculated as 
a ratio of the area of the first 4 harmonic peaks of AF activity to the total area 
spectral power spectrum (c-20 Hz). The intra-atrial defibrillation thresholds 
(ADFTso) were determined with an up-down-up protocol. Additional shocks 
were delivered to determine a probability density function. In all cases, 
QRS-synchronous shocks were randomized to be delivered randomly, or 
only when the 01 was greater than 0.5. 
Results: The 01 varied over time (mean 01 0.42 f 0.04, maximum 0.66 
+ 0.08, a minimum of 0.20 * 0.06). The 01 changed rapidly with maximal 
durations of high organization (01 > 0.5) of 2.5 f 2 set (range 1 X-5.0 set). 
The ADFTso for QRS synchronized shocks was 194 & 64 volts, versus 142 
f 58 volts for shocks synchronized to both the QRS and the point when the 
01 exceeded 0.5 (p = 0.0016). 
Conclusion: AF signals show a high amount of variability. Shock ef- 
ficacy is increased when shocks are delivered during periods of high AF 
organization as determined by the 01 method. 
Continued from page 11A 
515 bm. 
El 83 6 Sustained Symptomatic and Exercise Improvements at 6 Months Following Percutaneous Direct 
Myocardial Revascularization Guided by Biosense’” 
Left Ventricular Mappina in Patients With Refractorv 
lschemic Syndromes - 
Ran Kornowski, Donald S. Bairn, Jeffrev W. Moses, Mun K. Hong, 
Annette Stine, David J. Cohen, Deborah Wallace, Richard E. Ku&z, Martin 
B. Leon. Washington Hospital Center; Washington, DC; Beth 
Israe/-Deaconess Hospit& Boston, Lenox Hi/iHospifa/, N): USA 
Background: Laser myocardial revascularization has been explored as an 
alternative treatment strategy for patients with chronic refractory myocardial 
ischemic syndromes who are not candidates for conventional modes of 
coronary revascularization. 
Methods: We used the Biosense” 3D magnetic guidance system for 
direct myocardial revascularization (DMR) in 77 pts with refractory ischemic 
coronary syndromes (56 men, age 61 i 11 years, EF = 48 + 11%) to perform 
percutaneous DMR using Ho:YAG laser @2J x 1 pulse per laser site. 
Results: Procedural success (laser channels placed in pre-specified is- 
chemic target zones) was achieved in 76/77 pts. The average number of 
laser channels was 26 i 10 (range 11-50). Treatment zones were: anterior 
(30), apex (I), lateral (32), inferior (25), and postero-lateral (24). Major in- 
hospital cardiac adverse events were 2.6%; including no death or emergent 
surgery; 1 post-procedure pericardiocentesis for pericardial effusion, and 1 
minor embolic stroke. Out of hospital to 6 mos adverse cardiac events were 
2.6% including no death, one pt with non-Q wave Ml and one pt with stroke. 
Exercise duration after DMR increased from 387 + 178 sees (b/l) to 451 * 
164 and 493 * 162 sees @ 1 and 6 mos (p = 0.0001). Time to onset of angina 
increased from 293 f 166 sets (b/l) to 374 * 176 ‘and 420 f 166 sees-@ 1 
and 6 mos (p = 0.0001). Importantly, the time to ST segment depression (21 
mm) during exercise also increaseb from 327 f 177 s&s (b/l) io 399 & i69 
and 440 f 178 sets @I and 6 mos (p = 0.001). Angina (CCS) improved 
from 3.3 f 0.5 to2.1 f 1.1 and2.0f 1.2 @Band 6 mos (p < 0.001). Angina 
stability score showed sustained improvement from 36 f 26 (b/l) to 67 + 28 
and 72 f 29 value @3 and 6 mos (p < 0.001). Nuclear perusion imaging 
studies using a dual isotope technique did not show significant improvements 
at one and 6 months. 
Conclusions: Percutaneous DMR guided by Biosense” LV mapping 1) 
is feasible and safe; 2) reveals improved angina and prolonged exercise 
duration sustaining up to 6 mos following the procedure in most patients. A 
blinded randomized clinical trial is underway to establish definitive therapeutic 
value. 
POSTER 
1 11041 Evaluating Outcomes in Coronary Artery 
Disease 
Monday, March 13,2000, Noon-2:00 p.m. 
Anaheim Convention Center, Hall A 
Presentation Hour: Noon-l :00 p.m. 
/ 1104-l 31 Persistent Chest Pain (PCP) in Women at 
Six-Week Follow-Up: The NHLBI-Sponsored WISE 
Study 
B. Delia Johnson, C. Noel Bairey Merz, Shetyl F. Kelsey, Barry Sharaf, 
Carol E. Cornell, Eileen M. Handberg-Thurmond, Cheryl Rickens, 
Diana Pakstis. University of Pittsburgh, Pittsburgh, PA,.USA 
The Women’s lschemia Syndrome Evaluation (WISE) aims to determine 
approaches that will improve diagnostic reliability of cardiovascular testing 
in women. To be eligible for WISE, women are referred to angiography for 
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suspected ischemia. Of the 540 women who presented with chest pain, half 
continued to have chest pain at B-week follow-up. 
Methods: Women with PCP (N = 293; 54%) were compared to women 
without PCP (N = 247; 46%) six weeks later. 
Subjects: The women’s ages ranged from 21 to 86 years (mean 58 rt 11). 
Overall, 209 (39%) of the 540 women had coronary artery disease (CAD), 
defined as 150% luminal diameter stenosis, and 129 (24%) women had 
>70% stenoses. 
Results: Coronary artery disease (CAD 2 50%, CAD 2 70%, CAD sever- 
ity score, prior or subsequent PTCA and CABG) was not related to PCP. No 
coronary risk factors examined, including obesity, predicted PCP; nor did 
race, education, marital status, environmental stress, or diabetes. Women 
aged ~50 were more likely to have PCP (63% vs. 51%, p = 0.02) as did 
premenopausal women (62% vs. 51%, p = 0.04). PCP was more frequent in 
women with a history of irregular menstrual cycles (63% vs. 52%, p = 0.03) 
hysterectomy (57% vs. 48%, p = 0.04) before age 40 (64% vs. 50%, p = 
O.Ol), and a history of polycystic ovary disease (76% vs. 52%, p = 0.004). 
Baseline symptom characteristics related to PCP included location (neck: 
66% vs. 50%, p = 0.007; left arm: 63% vs 48%, p = 0.02; but not substernal 
pain), atypical angina classification (66% vs. 50%, p = O.OOl), frequency of 
chest pain (every day or more: 62% vs. 48%, p = 0.002) history of unstable 
angina in the last 6 weeks (64% vs. 47%, p = O.OOOl), and symptoms waking 
at night (64% vs. 47%, p = 0.003). These associations did not change when 
controlling for age. 
Conclusions: While not indicative of atherosclerosis, persistent chest 
pain in women catheterized for suspected ischemia is strongly associated 
with younger age, baseline symptoms, and reproductive abnormality. These 
results highlight the need for more efficient assessment tools for chest pain 
in women. 
1104-l 4 Effect of End-of-Month Admission on Discharge 
Qualitv Parameters for Acute Mvocardial 
Infarction Patients 
James P. Smith, Kim A. Eagle, Sugata K. Das, Thomas T. Tsai, Dean 
J. Karavite, Pamela L. Russman, David Bruckman, Rajendra H. Mehta. The 
University of Michigan Heart Care Program, Ann Arbor, Michigan, USA 
Background: Discontinuity of care occurs at academic centers as housestaff 
and faculty periodically switch services. Previous studies have not addressed 
whether this transfer of care to a new inpatient team affects the quality of 
care received. The present study examines quality of care, measured using 
standard discharge quality indicators, in acute Ml patients (pts) hospitalized 
during the switch of inpatient physician teams. 
Methods: Retrospective analysis was performed using a database of 905 
pts diagnosed with acute MI and cared for on an inpatient cardiology service 
from 1995-l 998. Because faculty and housestaff rotate services on the first 
of each month at our institution, patients admitted on the last four days of the 
month and discharged after the first of the subsequent month were denoted 
“end-of-month (EOM)” pts; all others were considered “mid-month” pts. 
Results: Of the 905 pts available for analysis, 815 were discharged 
alive, 698 (85.6%) of whom were admitted mid-month and 125 (14.4%) at 
EOM. Discharge quality indicators included whether a lipid profile was ob- 
tained during admission and whether selected medications were prescribed 
at discharge (ASA, beta-blocker, ACE-I, and lipid-lowering agents). Individual 
patient variables that may have influenced the selection of discharge med- 
ications were not considered in this analysis, therefore unadjusted values 
are reported. No statistically significant differences in quality indicators were 
observed between the two groups (see table). 
End-of-Month 
n % 
Mid-Month 
” % 
P-value 
(chi-square) 
ASA on d/c 109 87.2 664 85.1 0.54 
BB on d/c 93 74.4 588 75.4 0.81 
ACE-I on d/c 51 40.8 370 47.4 0.17 
Lipid profile 109 67.2 641 82.2 0.17 
Hyperlipidemia Rx 55 44 402 51.4 0.12 
Conclusion: (1) Admission during the last four days of the month and 
discharge after the switch of inpatient physician teams does not have a 
large effect on quality of care as measured by standard discharge quality 
indicators at our instituion. (2) This may reflect ongoing quality assurance 
efforts directed not only at physicians, but also at nurses and pts. 
I 1104 1.5 What Impact Does the Type of Lesion (A, Bl , B2, C) Have on Cath Lab Clinical and Economic 
Outcomes? 
Jay Midwall, Gail Grasso, Salvatore L. Battaglia, April W. Simon, Edmund 
R. Becker, Steven D. Culler. ColumbialHCA, Nashville, TN; Emory 
University Atlanfa, GA, USA 
Background: Variations in lesion type are important clinical indicators but 
their influence on cath lab clinical and economic outcomes are not well 
understood. 
Methods: We analyzed cath lab direct costs and device costs, total and 
procedural time, length of stay, complication rates, and procedural result for 
837 interventional patient encounters in four hospitals. Clinical and economic 
data were collected through the CathSource’” Database for the period 4/99 
thru 6/99. Patient cath lab encounter was classified according to the highest 
lesion treated - A, Bl, 62, and C consistent with ACC definitions. 
Results: As the type of lesion becomes more difficult, cath lab costs, 
times, and failure rates for these procedure increase significantly. Mean cath 
lab costs (direct and devices) incmase by more than $1,000 per patient and 
mean time (total and procedure) average of over 12 minutes for patients with 
Type C lesion compared to Type A lesion. Lesion type had no significant 
(p < 0.01) impact on any of the nine patient complications (abrupt closure, 
hematoma, emergency CAB, etc.) analyzed. 
A Bl 82 c D level 
Direct Cath Lab Cost 
Device Cost 
Total Time (min\ 
$2,241 $2,800 $2,734 $3,343 b.0001 
$1,755 $2,277 $2,250 $2,788 0.0001 
80 79 78 92 0.0001 
Procedure irne (min) 
Length of Stay (days) 
Failure Rate 
34 41 37 49 0.0001 
2.3 3.8 3.3 3.6 0.04 
0.0% 5.0% 1.2% 8.1% 0.16 
N 41 118 343 335 
Conclusions: For physicians and cath lab administrators the type of 
lesion, especially Type C lesion, has important implications for cath lab 
clinical and economic outcomes. 
1 1104-l 6 1 Are Patients With Known or Suspected Coronary 
Artery Disease and Normal Stress Imaging 
Studies at Low Risk for Adverse Outcomes: 
Meta-Analysis of Stress Echocardiography and 
SPECT 
Rory Hachamovitch, Jeffrey Schnipper, Yinong Young-Xu. N.y 
Hospital-Cornell Medical Cenfer, NY NL: USA 
Background: Stress testing is commonly performed using both SPECT and 
echocardiographic (Echo) techniques to evaluate risk of adverse outcomes. 
We evaluated whether a normal stress imaging study (Ni) performed in 
patients (pts) with known or suspected coronary artery disease (CAD) is 
associated with a low risk, defined as a hard event rate (HE; cardiac death, 
nonfatal Ml) of less than 1% per year of follow-up. 
Methods: A systematic review of published reports on stress testing in 
pts for CAD from the MEDLINE data base (1966 to June 1999) limited to 
Echo or SPECT identified 26 nonredundant reports (14 Echo, 12 SPECT) 
from which data could be extracted. Random effects models were used to 
calculate summary estimates of HE rates per year and 95% confidence 
Intervals. Meta-regression was performed separately for each modality and 
the combined reports to compare HE rates between modalities. 
Results: Summary estimates of HE rates per year were 1.3%/yr (0.8-I .7%) 
for Nl Echo and 0.7%/yr (O&0.9%) for Ni SPECT. Stratification of the re- 
ports by clinical risk of the cohort, quality of the studies or the HE rate in 
the overall cohort reported (HE Total) revealed that the estimate of HE risk 
remained over 1% in all Ni Echo subgroups and ~1% in all Nl SPECT 
subgroups. Meta-regression revealed that the quality of the study and HE 
Total did not alter the HE rate in Nl studies using both Echo and SPECT. 
However, the clinical risk of the cohort altered the HE rate in Nl Echo (p c 
O.OOOl), but not in Nl SPECT. Meta-regression of all 26 reports revealed 
that after adjusting for the clinical risk of the population, the modality used 
significantly effected the HE rate in Nl studies (p = 0.004). 
Conclusions: Meta-analysis of 26 reports of stress imaging demon- 
strated that normal stress SPECTcan identify pts at low riskfor HE (cl%/yr), 
but Nl stress Echo studies are associated with higher risk. 
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Educational Programs 
Monday, March 13, 2000, 1:30 p.m.-.%00 p.m. 
Anaheim Convention Center, ACC Central, Hall D 
L--l.l 1502 1 Four-Dimensional Virtual Pictures: A New Method for Teaching Cardiac Embryology 
Jean-Marc Schleich, Claude Almange. Unite de Cardiopathies 
Cong&itales, DPpartement de Cardiologie et Maladies Vasculaires, Centre 
Cardio-Pneumologique, C. H. R. U. Rennes, France 
Background: Teaching embryology is a difficult task as it requires to under- 
stand the representation and the motions of many complex phenomena. In 
classical embryology textbooks, this evolution is usually described by means 
of drawings between which it is difficult to imagine the spatial and temporal 
links, which are in fact the keystone of descriptive embryology. 
Methods: We have synthetized the bibliographic data of different text- 
books of embryology. Every stage of heart evolution, according to this syn- 
thesis, has been ratified by a group of experts in cardiac embryology. Three- 
-dimensional objects in synthetized pictures have been modelized for each 
anatomical structure involved in the different stages of human heart develop- 
ment: fertilization, development of trilaminar germ disc, formation and folding 
of the primitive heart tube, morphogenesis of the heart chambers and valves, 
development of the aorta and the pulmonary artery. 
Results: An animation wholly realized in virtual pictures, describing every 
process of heart development, from fecundation phase to the last cardiac 
events has been realized. This animation, completed by two explicative video 
sequences, describes the different motions and movings involved in heart 
evolution. The objects realized in 3-D for this animation can be seen thanks 
to an open GL viewer directly integrated. Besides, access to a data base 
including several echocardiography video sequences is possible and allows 
to get used to the real forms of acquisition and bibliography references are 
recorded. 
In conclusion, we have realized and produced a videotape and a 
cederom on the human embryologic development to demonstrate that using 
virtual pictures in teaching improves substantially the comprehension of com- 
plex phenomena. The contribution of this dynamic point of view represents a 
new teaching means. 
1502-2 Interactive Internet Based Continuing Medical 
Education Program for Health Care Providers 
Managing Congestive Heart Failure 
Richard M. Steingart, Steven M. Zeldis, Herbert Hirsch, 
MaryEllen Coglianese, Judy Lum, Dorothy Lane. Winthrop-University 
Hospital Mineola, NY; Health Sciences Center; SUNY at StonyBrook, USA 
We designed the “Case Study in Congestive Heart Failure” (HTTP://www. 
WINTHROP.CHFCME.COM) as an interactive multimedia CME experience. 
The CME script is based on published Agency for Health Care Policy and 
Research (AHCPR) congestive heart failure (CHF) guidelines. Throughout 
the 11 chapter CME, participants choose diagnostic and treatment options 
pertinent to the management of a patient with CHF. The visual and sound ca- 
pabilities of the internet provide a realistic ease presentation as the participant 
works through the CME. For example, cardiac graphics including electrocar- 
diograms, phonocardiograms, cineangiograms, radionuclide stress tests and 
echocardiograms are made available for real time review. Participants are 
queried at key points in the CME for their management and diagnostic deci- 
sions, with immediate feedback as to whether these correspond to AHCPR 
evidence based guidelines. Participants are also given the rationale for the 
AHCPR guidelines and references are provided. Dietary and other patient 
education resources are available via downloads. After all 11 chapters are 
completed (in as many sessions as necessary) and all questions are an- 
swered, participants may apply on line for CME credit. These costs are 
covered through an unrestricted educational grant. 
In a sample of the first 509 CME participants (84% physicians, 16% 
NPs or PAS) 18% responded that the online presentation of the CME was 
excellent or superior, while 12% felt it was average; 99% requested more 
CME on the internet. In the CME exercise, over 80% of respondents correctly 
used diuretics and ACE inhibitors and knew the AHCPR indications for 
hospitalization for CHF, but only 42% correctly prescribed anticoagulation 
for paroxysmal atrial fibrillation. Participants usually endorsed a nurse run 
heart failure service (89%), but were unlikely to refer a patient with class 11-111 
CHF for experimental drug protocols (12%). CME participants represent a 
minority of the site visitors, as there are more than 55 visits/day (46,000 in 
total) with 96% coming from the U.S. 
Conclusions: The internet is a powerful tool for the dissemination of 
CME. Based on this experience, anticoagulation and clinical research in 
CHF appear to be fruitful areas for future educational programs. 
ORAL 
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Molecular and Cellular Cardiology 
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2:00 p.m. 
ELI 411 1 Vascular Injury Induces Posttranscriptional Regulation of the Id3 Gene 
Martin E. Matsumura, Beiyang Wei, David R. Lobe, Cathy Jeon, Coleen 
A. McNamara. University of Virginia Medical Center, Charlottesville VA, USA 
Background: The molecular mechanisms that regulate the phenotypic mod- 
ulation and proliferation of smooth muscle cells (SMC) of the vasculature in 
response to injury are poorly understood. The “Id” class of helix-loop-helix 
transcription factors are known to regulate growth and differentiation in a 
variety of cell types, however their expression in SMC and in vascular lesion 
formation has not been studied. In the present study we describe the cloning 
of a novel isoform of the id3 gene (ld3a) and examine its expression in 
cultured SMC and in vascular lesions. 
Methods: The yeast two-hybrid system was used to clone Id genes 
from a rat aortic SMC cDNA library. Using ubiquitous E-proteins as bait, Id3 
and ld3a were cloned. RT-PCR was performed on mRNA extracted from 
quiescent and serum stimulated SMC using primers which amplified both Id3 
and ld3a. In situ hybridization was used to examine the expression patterns 
of Id3 and ld3a after balloon injury of the rat carotid, as well as the expression 
pattern of a previously cloned human isoform of Id3 (ld3L) in human carotid 
endarterectomy specimens. 
Results: ld3a is the product of alternative splicing of the Id3 gene and 
differs from Id3 in the inclusion of a 115bp “coding intron” located downstream 
of the HLH region. Translation of ld3a results in a protein containing a 
unique 29aa carboxyl terminus vs. ld3. RT-PCR of quiescent and serum 
stimulated SMC demonstrated that expression of Id3 and ld3a mRNA are 
differentially regulated by serum. Furthermore, Id3 and ld3a mRNA have 
unique expression patterns in vivo. Unlike ld3, ld3a mRNA is not detected in 
the normal rat carotid. However following balloon injury ld3a was abundantly 
expressed in the neointimal layer. Finally, we demonstrated that mRNA 
of the human Id3 alternative splice isoform (ld3L) is expressed in human 
atherosclerotic lesions. 
Conclusion: Alternative splicing of the Id3 gene may represent an im- 
portant mechanism by which Id3 function is regulated during vascular le- 
sion formation. Further understanding of the function and regulation of the 
Id3 isoforms in SMC may lead to a better understanding of the molecular 
mechanisms that regulate the growth and phenotypic modulation of SMC in 
response to vascular injury. 
2:15 p.m. 
41 l-2 Short Polymers of Arginine Inhibit Myointimal 
Hyperplasia: Efficient Intracellular Translocation and 
Activation of Nitric Oxide Synthesis 
Shiro Uemura, C. Garrison Fathman, Jonathan B. Rothbard, John P. Cooke. 
Deparfment of Medicine, Stanford University School of Medicine, Stanford, 
CA, USA 
Background: We recently discovered that short polymers of arginine ef- 
ficiently translocate across the cytoplasmic membrane independent of the 
basic amino acid transporter, and degrade into arginine monomers after 
translocation. We evaluated the kinetics and biological effects of heptamers 
of L- and D-arginine (L- and D-R7) in vascular cells. In particular, we as- 
sessed the effects of these oligopeptides on the NO synthesis pathway and 
vascular cell proliferation. 
Methods and Results: Human umbilical vein endothelial cells and rab- 
bit vascular segments were incubated in medium containing biotin-labeled 
L-R7 or D-R7. Histological analysis revealed that both polymers rapidly and 
efficiently translocated through the vessel wall, and into the vascular cells 
in a dose and time dependent fashion. To evaluate the biological effects of 
the polymer translocation on myointima formation, rabbit jugular vein seg- 
ments were incubated with polymers (IO FM, 30 minutes) or vehicle prior 
to arterial interposition grafting. Planimetric measurement 28 days after the 
surgery revealed that L-R7 and D-R7 substantially reduced myointima for- 
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mation compared to control (intima/media ratio: Control; 1.5 It 0.5, L-R7; 0.4 
f 0.2, D-R7; 0.8 f 0.2, p < 0.05). Furthermore, basal NOx production from 
L-R7 treated grafts was significantly higher than that of both control and D-R7 
treated graft. Studies in vitro of cultured VSMC revealed that both polymers 
also exhibit an NO independent inhibition of VSMC proliferation. 
Conclusions: Short polymers of arginine not only have the unique ability 
of vascular cell translocation but also may have beneficial biological effects, 
potentially useful in therapy to reduce myointimal hyperplasia. Furthermore, 
these polymers, when fused with other molecules, may be useful in intracel- 
lualr delivery. 
2:30 p.m. 
41 l-3 Cardiovascular Basic Helix-Loop-Helix Factor-l, a 
Novel Transcriptional Repressor Expressed 
Preferentially in the Developing and Adult 
Cardiovascular System 
Michael T. Chin, Koji Maemura, Shinya Fukumoto, Mukesh K. Jain, Matthew 
D. Layne, Masafumi Watanabe, Chung-Ming Hsieh, Mu-En Lee. Brigham & 
Women’s Hospital, Boston, MA, USA 
We have cloned a novel bHLH factor that interacts with arylhydrocarbon 
receptor nuclear translocator (ARNT) in a yeast two hybrid screen of a hu- 
man heart cDNA library. Cardiovascular helix-loop-helix factor (CHF)-1 is 
expressed in the developing cardiovascular system and is distantly related 
to the hairy family of transcriptional repressors. At day 8.5 of mouse embryo 
development, the expression of CHF-1 is first detected in the primitive ven- 
tricle of the primordial heart tube and persists throughout gestation. In rat 
hearts, this expression is downregulated after birth, concurrent with terminal 
differentiation of cardiomyocytes. In the developing vasculature, CHF-1 first 
appears in the dorsal aorta at embryonic day 9.0, which precedes the re- 
potted expression of the smooth muscle cell (SMC) markers SM22or, smooth 
muscle cy-actin, CRFQ/SmLIM and smooth muscle myosin heavy chain. In 
contrast to the heart, expression of CHF-I persists at high levels in adult 
aorta. In an in vitro system of SMC differentiation, CHF-1 mRNA was barely 
detectable in undifferentiated ceils but was induced highly in differentiated 
SMC. To determine whether CHF-I might affect the function of ARNT, we 
performed transient transfection studies. Cotransfection of CHF-I inhibited 
ARNT-dependent transcription by 85%, and CHF-1 inhibited the transcription 
in a dose-dependent manner. Our data suggest that CHF-1 functions as-a 
transcriptional repressor and may play an important role in cardiovascular 
development. 
2:45 p.m. 
141 l-4 1 Novel Basic Helix-Loop-Helix Proteins Expressed in 
Heart Repress Transcription by Recruiting mSin3 
and NCoR 
Tatsuya iso, Larry Kedes. University of Southern California, Los Angeles, 
CA, USA 
We have cloned two novel bHLH proteins, HERPI and 2 (E related 
Repressor erotein). Their deduced amino acid sequences have significant 
similarity with the HESl, a negative regulator of neurogenesis and an effec- 
tor of the Notch signaling pathway. While, like HESI, HERPI and 2 also act 
as transcriptional repressors in cultured cells, there are two major protein 
sequence differences. Strictly conserved amino acids in the HES family, a 
proline residue in the basic region and a WRPW tetrapeptide in the carboxy 
terminus, are replaced in HERPl and 2 by glycine and YRPW, respectively. 
To determine whether these structural peculiarities reflect functional differ- 
ences, luciferase assays were carried out using several deletion mutants of 
HERPI. That result showed that unlike HESI, the YRPW is dispensable for 
repressor activity of HERPl and that bHLH is the most critical component for 
repression. We carried out protein-protein interaction assays to determine 
which of several transcriptional co-repressors might partner with HERPI. 
Both in vivo and vitro, mSin3A and NCoR bound to the bHLH of HERPl, 
suggesting the mechanism by which HERPI represses transcription is to- 
tally different from the actions of HESI. Further, whereas gel shift assays 
confirmed the ability of HESI to bind to both class B and class C bHLH 
consensus binding sites, HERPI bound to neither. Thus, HERPI and 2 form 
a previously undescribed gene family related to the HES family but struc- 
turally and functionally distinct. The mRNA expression pattern of HERPI 
was highly tissue restricted. Northern blot analysis revealed that HERPI was 
abundantly and predominantly expressed in adult heart. In situ hybridization 
in mouse embryos showed that heart expression of HERPl was limited to 
ventricles, with no detectable expression in atria, valves, or great vessels. 
These results suggest that HERPI may play key roles in development, mat- 
uration and maintenance of the heart by acting as a chamber specific gene 
regulator. 
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El 411 5 Regulation of TNF-Induced Vascular Endothelial Cell Apoptosis by Racl : A Model for the Pro and 
Anti-Apoptotic effects of Reactive Oxygen Species 
Shailesh S. Deshpande, Jianping Huang, Piamsook Angkeow, 
Michitaka Ozaki, Kaikobad Irani. The Johns Hopkins University School of 
Medicine, Baltimore MD, USA 
Reactive oxygen species (ROS) has been implicated as mediators of tumor 
necrosis factor-alpha (TNF)-induced apoptosis. In addition to leading to cell 
death, ROS can also promote cell growth and/or survival. We investigated 
these two roles or ROS in TNF-induced endothelial cell apoptosis. Human 
umbilical vein endothelial cells (HUVECs) stimulated with TNF produced an 
intracellular burst of ROS. Adenoviral-mediated gene transfer of a dominant 
negative isoform of the small GTPase Racl (Racl N17) partially suppressed 
the TNF-induced oxidative burst without affecting TNF-induced mitochondrial 
ROS production. HUVECs were largely protected from TNF-induced apop- 
tosis. Expression of Racl N17 blocked TNF-induced activation of nuclear 
factor-kappa B (NF-I&), increased activity of caspase-3, and markedly aug- 
mented endothelial cell susceptibility to TNF-induced apoptosis. Rotenone, 
a mitochondrial electron transport chain inhibitor, suppressed TNF-induced 
mitochondrial ROS production, oroteolytic cleavage of procaspase-3 and 
apoptosis. Adenoviral expression of the activated form of Racl (RaclVlP) 
also led to production of ROS which were essential forthe activation of NF-KB. 
These findings show that Racl is an important regulator of TNF-induced ROS 
production in endothelial cells, and suggest that ROS, depending on their 
intracellular source and through their differential effects on NF-KB activation, 
and the processing and activity of the executioner caspase-3, have both pro 
and anti-apoptotic functions in endothelial cell biology. 
ORAL 
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853-l Improved Outcomes Associated With Stents in the 
Healthcare Cost and Utilization Project 
Charles Maynard, Nathan R. Every, Michael K. Chapko, James L. Ritchie. 
University of Washington, Department of Veterans Affairs, Seattle, WA, USA 
Background: Randomized trials have demonstrated improved outcomes for 
patients receiving stents, but whether this benefit extends to larger, unse- 
lected populations is uncertain. 
Methods: This study used 1996 data from the Nationwide Inpatient Sam- 
ple (NIS) of the Healthcare Cost and Utilization Project. The NIS is a 20% 
random sample of hospitals in 19 states and included over 6 million hospital- 
izations in 1996. Hospitalizations with procedure codes 36.01, 36.02, 36.05, 
or 36.06 (the code for stents implemented in October 1995) were selected. 
We compared hospital mortality and same admission coronary artery bypass 
graft surgery (CABG) in patients with stents vs. those with conventional coro- 
nary angioplasty (PTCA). Analyses were performed separately according to 
whether acute myocardial infarction (AMI) was the principal diagnosis. 
Results: In 1996, there were 100,318 procedures including 43,966 (44%) 
stents. In the group with AMI (n = 30,146), hospital mortality was lower in 
the stent group (2.7% vs. 4.2%, p c 0.0001) as was the use of same 
admission CABG (1.6% vs. 5.3%, p < 0.0001). After adjustment for baseline 
characteristics by logistic regression, the risk of death was 35% lower in the 
stent group (odds ratio = 0.65, 95% confidence interval = 0.57-0.75) and 
the risk of CABG was 70% less (odds ratio = 0.30, 95% confidence intrval 
= 0.25-0.35). Total median hospital charges were higher in the stent group 
($20,300 vs. $15,380), although median length of stay was similar (5 days 
in each group). In the group without AMI (n = 70,172), hospital mortality 
was 0.7% in the stent group and 0.9% in PTCA (p = 0.01). The use of 
same admission CABG was also less in the stent group (1.4% vs. 2.7%, p 
< O.OOOi). Total median hospital charges were also increased in the stent 
group ($26,520 vs. $22,260) as was median length of stay (3 vs. 2 days). 
After multivariate adjustment, death rates were similar in the 2 groups (odds 
ratio = 0.9, 95% confidence interval = 0.74-l .04), although the use of same 
admission surgery was almost 50% lower in the stent group (odds ratio = 
0.52, 95% confidence intrval = (X460.58). 
Conclusion: In this large national sample, stents were associated with 
improved hospital mortality in patients with AMI and lower use of same 
, 
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admission CABG in all patients. However, the lower rate of same admission 
CABG did not result in lower hospital charges in the stent group. 
2:15 p.m. 
Cost-Effectiveness of Emerging Antiproliferative 
Therapies That Reduce Restenosis After Coronary 
Angioplasty -. _ 
Thomas Alloggiamento, Gillian D. Sanders, Alex Khalessi, Otto S. Lin, Mark 
A. Hlatky, Alan C. Yeung, Douglas K. Owens. VA Palo Alto Health Care 
System, Palo Alto, California; Stanford University, Stanford, California, USA 
7.O%/yr) yielded similar results. For a 70 yo pt with both coronary disease and 
prior ischemic stroke, using a 0.5%/yr paradoxical stroke risk we calculated 
marginal C/E ratios of $1319/QALY, $23,835/QALY, and $88,79l/QALY for 
aspirin, aspirin/closure, and clopidogrel/closure respectively. A higher annual 
risk of paradoxical stroke produced similar results. 
.Conclusions: 1) Transcatheter closure with the amplatzer device is as- 
sociated with an increasingly favorable marginal C/E ratio as the risk of 
paradoxical embolism rises, 2) An increase in the risk of cardiovascular 
events or ischemic stroke risk mandates the use of antiplatelet therapy. 3) As 
concomitant antiplatelet therapy decreases the risk of paradoxical embolism, 
the marginal benefit of transcatheter closure falls. 
Background: Antiproliferative agents such as gene therapy, local drug de- 
livery, and intracoronaty radiation therapy (ICRT) may reduce restenosis 
following percutaneous treatment of coronary disease, but their cost-effec- 
tiveness remains unclear. Using ICRT as a model, we compared the marginal 
cost-effectiveness (MCE) of strategies incorporating antiproliferative therapy 
either as primary or secondary prevention of restenosis, relative to treatment 
without antiproliferative therapy. 
Methods: We developed a decision-analytic model to calculate costs, 
quality-adjusted life years (QALYs), and MCE for revascularization of single- 
vessel coronary disease. With data on outcomes, costs, and health benefits 
derived from three clinical trials, other literature, and an academic medieal 
center database, we used the following estimates in our base case: 
PKCXIUE 
Angioplasty 
Stenting 
ICRT 
B-month Angiographic Procedural 
Restenosis Rate cost 
32% $7,020 
22% 510,730 
17% $6,000 
We explored the sensitivity of MCE to likely ranges in restenosis rate and 
cost. 
Results: Angioplasty plus ICRT used at the time of first restenosis (i.e. for 
secondary prevention of repeat restenosis) costs $44,600 over 14.5 QALYs 
(MCE of $52,00O/QALY relative to angioplasty or stenting alone). Primary 
prevention of restenosis (i.e. use of ICRT up-front with initial angioplasty or 
stent) has a MCE of over $300,00O/QALY relative to secondary prevention, 
and over $150,00O/QALY relative to angioplasty or stent alone. For ICRT 
or any antiproliferative agent to achieve a MCE of less than $50,00O/QALY 
for secondary prevention of restenosis, the incremental cost of the new 
therapy must not exceed $6000 over the cost of angioplasty, and the 6-month 
restenosis rate following the new therapy must not exceed 17%. Furthermore, 
any associated side-effects of antiproliferative therapy must not increase 
annual mortality by over 1.45% or increase annual follow-up costs by $200. 
Conclusions: Use of antiproliferative therapy such as ICRT is expensive 
for primary prevention of restenosis, but may be cost-effective in secondary 
prevention, provided side-effects such as late restenosis are limited and 
therapy is relatively inexpensive. 
2:30 p.m. 
853-3 Patients With Patent Foramen Ovale: When Do We 
Seek Closure? 
Sushi1 Singh, David Thaler, Ziyad Hijazi, Deeb Salem, Stephen Pauker. 
Tufts-New England Medical Center, Boston, MA, USA 
Objective: To examine the quality-adjusted survival and cost-effectiveness 
of therapeutic options available for the prevention of cerebrovascular events 
in patients with patent foramen ovale. 
Methods & Data: Using a I&state Markov model we examined 8 dif- 
ferent strategies: 1) observation; 2) aspirin; 3) warfarin; 4) clopidogrel; and 
transcatheter closure with the amplatzer device, both 5) alone and in combi- 
nation with 6) aspirin, 7) warfarin or 8) clopidogrel. Estimates of the annual 
risk of stroke, morbidity and efficacy of interventions, and other critical values 
were taken from the literature. Costs were based upon published studies of 
cardiovascular and hemorrhagic events, as well as acquisition costs for drugs 
and the amplatzer device. We used balloon mitral valvuloplasty as a proxy 
for technical and professional costs of transcatheter closure. We calculated 
the marginal cost-effectiveness (C/E) ratio for each strategy for 3 different 
subgroups stratified by age, risk of coronary events and/or ischemic stroke, 
and prior stroke of presumed paradoxical origin. 
Results: For a 35 yo patient whose risk for cardiovascular disease is 
low, closure with the amplatzer device dominates other strategies, regard- 
less of any history of paradoxical stroke. Using an annual risk of paradoxical 
stroke of 05%/yr, we found for a 55 yo patient with a history of coronary 
disease and no history of ischemic stroke marginal cost-effectiveness ra- 
tios of $1427/QALY using aspirin alone, $8521/QALY for combined therapy 
with aspirin and closure, and $59,093/QALY using clopidogrel with closure. 
Higher values for the annual risk of paradoxical embolization (15%/yr and 
I 
‘2:45 p.m. 
853-4 Marginal Cost-Effectiveness of GPIIBNA Blockade 
Targeted to High-Risk Patients Undergoing 
Angioplasty 
Trevor Thompson, Elizabeth Mahoney, William S. Weintraub. Emory 
Universi& Atlanta, GA, USA 
Background: GPllb/llla blockers (GPB) can prevent events after coronary in- 
tervention (PCI) in high-risk patients. However, there is uncertainty regarding 
cost-effective selection of patients for GPB. 
Methods: All 4962 patients at Emory Hospitals undergoing 6062 PCI 
between 1993 and 1995 were included in a multivariable model to predict 
the in-hospital composite endpoint of death, Q and non-Q MI, or emergency 
revascularization. Predicted event probabilities (ER) from the model were 
used as cutpoints for therapy. Hospital costs (C) were determined from hos- 
pital bills and cost-to-charge ratios, and professional C from Resource Based 
Relative Value Scale methods. Survival was calculated as Kaplan-Meier es- 
timates from 21,535 patients, then discounted 3% per year. The marginal 
cost-effectiveness (MCE) of therapy for moving up 1 cutpoint, assuming 24% 
and 40% effectiveness (E) and $750 and $1000 C, was calculated as MCE 
of events averted (MCE-E), and of QALY gained (MCE-Q). 
Results: If patients with a greater than 7% probability of events received 
GPB at 24% E & $1000 C, 20.9% of patients would receive therapy at 
$13,953 per event averted and $9,077 per QALY compared to treating no 
one. As the cutpoint is decreased, additional patients are treated and the 
MCE rises. 
CUti3f %Rx ER cost MCE-E MCE-Q 
0% 100 4.86% $11,133 $76,081 $203,035 
3% 84.4 4.96% $10,990 $54,906 $80,755 
5% 40.1 5.37% $10,604 $32,657 $21,888 
7% 20.9 5.64% 510,446 $13,953 $9,077 
100% 0 6.39% $10.343 NA NA 
Conclusion: While anti-platelet therapy has been shown effective in 
preventing events, treating low-risk patients may not be cost effective. MCE 
analysis targeting high-risk patients can be helpful in providing decision 
support for patient selection. A cutoff for therapy of approximately 3% to 5% 
may be appropriate. 
3:00 p.m. 
853-5 Should Survivors of Myocardial Infarction be 
Screened for Risk of Sudden Death? 
A Cost-Effectiveness Analysis 
Paul A. Heidenreich, Gillian D. Sanders, Mark A. Hlatky, Kathryn 
M. McDonald, Douglas K. Owens. Palo Alto VA Health Care System Palo 
Alto, California; Stanford University Stanford, California, USA 
Background: Patients with inducible ventricular tachycardia with electro- 
physiologic testing (EPS) after myocardial infarction (Ml) are known to have 
a high risk of death Several trials have shown that a prophylactic defibrillator 
(ICD) can reduce death in high-risk patients. 
Methods: To determine the cost-effectiveness of a hypothetical screening 
program for survivors of Ml we developed a decision model based on data 
from a recently published study. A measure of ejection fraction (EF) and 
ventricular ectopy (Holter) are obtained for all patients. An EPS is performed 
if the EF is low or the Holter is abnormal. Patients with inducible ventricular 
tachycardia on the EPS receive an ICD. We used a Markov model to estimate 
life-time costs and quality adjusted survival (QALYs) for a cohort of 65 year 
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old MI survivors. Published study data indicate that 46% would undergo EPS 
and 7% would receive an ICD. 
Results: If no screening is done, the quality-adjusted survival is 8.834 
QALYs with lifetime costs of $84,356 per patient. If the ICD prevented 
100% of sudden deaths, then screening would increase survival by 0.063 
QALYs, and costs would increase by $5,077 (marginal cost-effectiveness: 
$81,755/QALY). If the ICD efficacy is ~80% then the cost-effectiveness ratio 
will be ~$IOO,OOO/QALY (figure). 
Conclusions: If the ICD efficacy in preventing sudden death is ~80% then 
screening is expensive compared with other commonly accepted therapies. 
3:15 p.m. 
853-6 Implications of Statin Use on the Health Burden and 
Economic Costs of Acute Coronary Syndromes 
Without ST Elevation: Prospective Registry of Acute 
lschaemic Syndromes (PRAIS) in the United 
Kingdom 
Julian R. Collinson, Marcus D. Flather, Keith A. Fox, lain Findlay, 
Erwin Rodrigues. Clinical Trials and Evaluation Unit, Royal Brompton and 
Harefield NHS Trust, London, UK 
Background: Acute coronary syndromes (ACS) without ST elevation are 
frequent causes of hospital admission. Statins reduce event rates in patients 
with ACS. We examined the impact of increasing the use of these medications 
on the cost of treating ACS without ST elevation. 
Methods: We enrolled 1046 patients with ACS without ST elevation from 
a representative sample of 56 hospitals in the UK (20 patients/centre) and 
followed them for 6 months. Patients had a good clinical history plus either 
ECG changes of ischaemia or prior history of coronary artery disease. The 
rate of death, non-fatal Ml, refractory angina or readmission for unstable 
angina was 30% at 6 months. We performed a cost analysis using the 
following cost drivers: length of stay (LOS), LOS in CCU, cardiac drugs, 
angiography, PCI, CABG, stress testing and readmissions over the 6 month 
follow-up. Sensitivity analyses were performed based on the observed 40% 
use of statins at 6 months (despite 80% being eligible according to UK 
guidelines) and assuming this was increased to either 80% or 100%. 
Results: Using the length of time taken to enrol patients, and the popula- 
tion served by the participating hospitals, we estimate that there are 120,000 
admissions each year for ACS without ST elevation in the UK. The overall 
incident rate for the UK (population 55 million) is estimated to be 1 in 500. 
Mean LOS was 6.3 days, LOS in CCU was 3 days, angiography occurred in 
26%, PCI in 8% (62% with stents) and CABG in 6% of patients. Estimated 
costs per patient over 6 months were f2561 (US$4277). The total costs over 
6 months for ACS without ST elevation are estimated to be f320 million ($520 
million) and approximately 2500 million ($800 million) per annum which is 
about 1.5% of the UK Health budget. About 50% of patients not currently 
receiving statins could receive benefit according to accepted guidelines. If 
in this group cardiovascular event rates are reduced by 25%, then in the 
group overall these rates may be reduced by 1 O-20%. This would results in 
cost savings of 1.5% and 2.8% if 80% were treated with statins and savings 
of 1.6% and 3.0% if all patients were treated, despite the increased drug 
costs. 
Conclusion: Our data show that ACS without ST elevation are associated 
with a major burden of mortality and morbidity. Health care costs are high 
even in a system where rates of intervention are low. Increasing the use of 
statins to levels at least as high as suggested in guidelines would reduce 
health burden and allow more effective resouce utilisation. 
POSTER 
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1125-l 3 More Malignant Than Cancer? Five-Year Survival 
Following a First Admission for Heart Failure in 
Scotland 
Simon Stewart, Kate Maclntyre, David J. Hole, Simon Capewell, John 
J. McMurray. CR/ in Heart Failure and Department of Public Health, 
University of Glasgow, Glasgow, UK 
Background: Heart failure (HF) is a growing but frequently underestimated 
problem. We tested the hypothesis that the prognosis for patients with HF 
severe enough to require hospitalization is worse than that associated with 
the most common types of cancer (Ca). 
Methods: All patients with a first admission to a Scottish hospital in 
1991 for HF, AMI or the four most common types of Ca specific to men 
and women were identified. Five-year survival rates and resultant loss of 
expected life-years for each condition were then compared. 
Results: In 1991 a total of 16,224 men had an initial admission primarily 
caused by HF (n = 3,241), AMI (n = 6,932) or Ca of the lung (n = 2,695), large 
bowel (n = 1,385), prostate (n = 1,211) or bladder (n = 760). Similarly, a total 
‘of 14,842 women were admitted for either HF (n = 3,606), AMI (n = 4,916), or 
Ca of the breast (n = 2,902), lung (n = 1,490), large bowel (n = 1,402) or ovary 
(n = 526). With the notable exception of lung Ca, HF was associated with the 
worst five-year survival rate overall, with 25% and 24% of men and women 
respectively surviving the follow-up period. The adjusted, relative-to-HF risk 
of short (<30-day) and longer-term (31 day 5-year) mortality in men was 
1.24 and 0.37 for AMI, 0.27 and 0.70 for prostate Ca, 0.64 and 0.89 for large 
bowel Ca and 1.86 and 2.89 for lung Ca. In women, the equivalent figures 
were 0.71 and 0.51 for AMI, 0.55 and 0.59 for breast Ca, 1.39 and 1.49 for 
ovarian Ca and 2.81 and 3.52 for lung Ca. All were statistically significant. In 
men, HF was associated with a loss of 16,400 expected life-years (median 
= 9 years/person) compared to 22,900 for AMI and 29,700, 8,700 and 3,000 
for Ca of the lung, large bowel and prostate. In women, the equivalent figures 
were 13,200 for HF (median = 7 years/person) compared to 17,300 for AMI 
and 18,300, 17,400 and 7,900 for Ca of the breast, lung and large bowel. 
Conclusions: A first admission for tiF is associated with a worse prog- 
nosis than AMI and heady all of the most common types of Ca. This, and the 
significant number of life-years lost in both sexes, demonstrates that: 1) HF 
is a serious health issue for both men and women, and 2) it deserves the 
kind of health-care response usually reserved for Ca. 
1 1125-l 4 ) Smoking and Mortality: A Propensity Analysis 
With Consideration of the Effects of Alcohol 
JoAnne Micale Foody, Christopher R. Cole, Eugene H. Blackstone, Michael 
S. Lauer. The Cleveland Clinic Foundation, C/eve/and, OH, USA 
Background: Cigarette smokinlg causes mortality, yet the extent of this 
risk has been challenged due to confounding and self-selection biases. 
Propensity analysis is a statistical method that allows for robust adjustment 
for potential biases and confounding factors. 
Methods: In 6099 adult participants (age > 30, mean age 46, 54% male) 
in the Lipid Research Clinic Prevalence Study who were current smokers 
[CS] (n = 2187), former smokers [FS] (n = 1746) or never smokers [NS] (n 
= 2166), 204, 157 and 152 deaths occurred, respectively, over 12 years. A 
propensity score for CS was generated based on age, alcohol and 25 other 
covariates that included medical, economic, occupational, and educational 
factors. 
Results: Adjusting for age only, CS predicted death (compared to NS, 
RR 2.22, 95% Cl 1.79-2.76, p < 0.0001 and compared to FS, RR 1.76, 95% 
Cl 1.24-2.50, p = 0.002). Adjusling by propensity score, smoking remained 
predictive of death in CS compared to NS (RR 2.69, 95% Cl 1.97-3.67, P 4 
0.0001) and FS (RR 1.79, 95%CI 1.26-2.55, P = 0.001). Smoking interacted 
with alcohol; smokers who drank had an increased risk for death (adjusted 
RR 2.00,95% Cl 1.42-2.82, p < 0.0001) whereas smokers who did not drink 
had marked risk (RR 4.74, 95% Cl 3.24-6.92, p < 0.001). 
Conclusions: The use of a propensity score demonstrates that it is 
unlikely that the strong association between smoking and mortality risk is 
significantly biased and confounded. Furthermore, nondrinking smokers have 
higher mortality risk. 
1125-l 5 The Effect of Obesity on Long-Term Survival 
Following Coronary Bypass 
Nancy J.O. Birkmeyer, Charles A.S. Martin, David C. Charlesworth, 
Felix Hernandez, Bruce J. Leavitt, Jeremy R. Morton, Hebe Quinton, Elaine 
M. Olmstead, Gerty T. O’Connor, Stephen J. Lahey. For the Northern New 
England Cardiovascular Disease Study Group, Lebanon, New Hampshire, 
USA 
Background: Previous work by this group and others has shown that obese 
patients were no more likely than non-obese patients to experience in-hos- 
pital mortality with coronary bypass (CABG). In this study we examine the 
effect of obesity on long-term survival after discharge from the hospital fol- 
lowing CABG for the 10,686 patients who were discharged alive following 
CABG in northern New England from l/92 through 4196. 
Methods: Data on potentially confounding variables including: patient 
characteristics, heart disease severity, comorbidities, and the details of treat- 
ment, were collected prospectively. Patient records were linked to the Na- 
tional Death Index to assess out of hospital vital status (mean follow-up = 
2.7 years, range = cl-5 years). Body mass index (BMI) was used as the 
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measure of obesity and was categorized as follows: non-obese (l-74th%-ile: 
BMI < = 30), obese (75-94th%-ile: BMI = 31-36) and morbidly obese (P = 
95th%-ile: BMI > = 37). To assess the effects of obesity on mortality while 
controlling for confounding variables, we used a Cox proportional hazards 
model to calculate adjusted hazard ratios (HA) and 95% confidence intervals 
(Cl). 
Results: There were 717 deaths and 29,023 person years of follow-up. 
While obesity was not associated with excess mortality in the absence of 
diabetes, morbid obesity was associated with significantly increased risks of 
mortality in both diabetic (p = 0.022) and non-diabetic patients (p = 0.025). 
Non-Diabetic Diabetic 
HR Cl HR Cl 
Non-Obese 
*** I** 
1.48 1.22-l .79 
Obese 0.94 0.70-l .27 1.49 1.10-2.01 
Morbidly Obese 1.79 1.08-2.98 1.77 1.09-2.87 
*“The non-obese, non-diabetic group is the reference category to which the other groups 
were compared. 
Conclusions: These data indicate that both the degree of obesity and 
diabetes should be factored into clinical decisions regarding the risks and 
benefits of CABG in obese patients. 
I 1125 16 Risk Factors, Ethnicity and Type of Treatment Predict Need for Late Repeat Revascularization in 
Patients Presenting for Treatment of Coronary 
Artery Disease 
Colman Ryan, Richard E. Shaw, Alex Zapolanski, Mary C. Murphy, 
Felix Millhouse, Michael B. Pliam, Laurel Mengarelli. San Francisco Heart 
Institute at Seton Medical Center, CHW Bay Area Region, Daly (2% 
California, USA 
Background: To date very little has been published evaluating the inter- 
play between cardiac risk factors, ethnicity and type of treatment and the 
association of these factors with need for repeat revascularization following 
percutaneous coronary intervention (PCI) or coronary bypass graft surgery 
(CABG). The purpose of this study was to evaluate these factors in a large 
series of patients with longterm followup. 
Methods: A retrospective analysis of prospectively collected data was 
done on a series of 3,703 consecutive patients presenting at a single in- 
stitution for treatment of coronary artery disease between January 1, 1992 
and December 31, 1996. All eligible patients were followed using a standard 
questionnaire and responsible physicians were contacted to verify all late 
medically related events. Cox Proportional Hazards Regression Modeling 
was used to analyze the association of patient risk factors, ethnicity, and type 
of treatment utilized on the need for further revascularization procedures at 
followup. 
Results: Of the patients presenting for initial treatment, Filipinos com- 
prised the largest ethnic group (527 or 14.2% of the patient sample). PCI 
was performed in 1151 patients with a 1.3% mortality rate and CABG was 
performed in 2552 with a mortality rate of 4.2%. Of the 3509 patients dis- 
charged alive from the hospital, follow-up was obtained on 3,130 patients, 
or 89% of the eligible patients. Mean time to followup was 20 months. Re- 
peat revascularization was required in 494 (15.8%) of patients. Cox analysis 
demonstrated that the variables associated with the need for repeat revas- 
cularization were: 1) PCI as initial treatment (p < O.OOOl), 2) Filipino ethnicity 
(p < 0.01) 3) history of diabetes (p < 0.05), 4) presence of triple vessel 
disease (p < 0.05) 5) initial presentation with acute myocardial infarction (p 
< 0.05) and 6) patient age greater than 65 at initial treatment (p x 0.05). 
Conclusions: The results of this study suggest that although early mortal- 
iky is higher, CABG may be a more durable treatment than PCI for coronary 
artery disease. Filipino patients or those who present with diabetes, triple 
vessel disease, myocardial infarction or advanced age are at higher risk for 
needing subsequent repeat revascularization procedures. Early intervention 
with these patients may help to avoid the need for late revascularization 
procedures. 
ORAL 
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414-l Heart Rate Recovery immediately Following 
Exercise Testina: A Powerful New Predictor of 
Mortality I’ 
Christopher Ft. Cole, JoAnne M. Foody, Eugene H. Blackstone, Michael 
S. Lauer. C/eve/and Clinic Foundation, Cleveland, OH, USA 
Background: The fall in heart rate immediately following exercise is thought 
to be due primarily to vagal reactivation, Since vagal activity is an important 
marker of prognosis we hypothesized that heart rate recovery (HRR) following 
exercise may have significant prognostic implications. 
Methods: Healthy adults enrolled in the Lipid Research Clinic Preva- 
lence Study without heart failure, coronary or vascular disease, rhythm dis- 
turbances or on beta-blockers or digoxin who underwent treadmill testing (n 
= 5234, age 45 i 0, 61% male) were followed 12 years. HRR was defined 
as the hear-l rate change from peak to 2 minutes recovery. Abnormal HRR 
was defined using the cutpoint with the maximum log-rank x2 for all possible 
cutpoints between the 10th and 90ih percentiles (abnormal HRR _’ 42 beats). 
Results: An abnormal HRR was present in 1719 (33%) subjects. There 
were 325 deaths. In univariate analyses, a low HRR was predictive of death 
[figure] (Relative Risk [RR] 2.58, 95% Cl 2.06 to 3.20, P < 0.0001). Adjust- 
ing for age, gender, resting blood pressure, diabetes, smoking, cholesterol, 
medications, and MET. achieved, a low HRR remained predictive of death 
(adjusted RR 1.47, 95% Cl 1.17 to 1.85, ,y” = 11, P < 0.001). 
Conclusion: In this healthy, population based cohort, a decreased HRR 
following graded treadmill exercise was a powerful and independent predictor 
of mortality. 
4:15 p.m. 
IIII 414 2 Overlapping Cycle Index: A Marker for the Prediction of the Outcome of Near-Defibrillation Threshold 
Shocks 
Nipon Chattipakorn, Parwis C. Fotuhi, Raymond E. Ideker. The University of 
Alabama at Birmingham, Birmingham, AL, USA 
Ventricular defibrillation is probabilistic and shock-strength dependent. We in- 
vestigated the relationship between defibrillation outcome and postshock ac- 
tivation pattern for shocks of the samestrength [-50% probability of success 
for defibrillation (EDsc) to yield equal defibrillation success (S) and failure (F)]. 
Methods: In each of 5 pigs, IO shocks at EDss were delivered after 10 s 
of VF and epicardial electrograms were recorded from a 504-electrode sock. 
Intercycle interval (ICI, time between successive postshock cycles), wave- 
front conduction time (WCT, time between the earliest and latest activation 
of a cycle), and overlapping cycle index (WCT cycle “n”/lCI cycle “n + 1”) 
were determined for the first 5 postshock cycles. An index < 1 indicates no 
overlap between successive cycles. 
Results: Of 50 defibrillation attempts, 25 were S. The ICI and WCT of 
cycle 1 were not different between S and F. However, starting at cycle 2, ICI 
*= P < 0.01 vs. 1CI.F 
709 #= P < 0.05 vs. WCTS 29 
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was longer, and WCT was shorter for S than F. Overlapping cycles were oniy 
found in F (index > 1). 
Conclusion: Shock outcome is not determined by the activation pattern 
of cycle 1. Overlapping cycle index, however, can be used to predict the 
defibrillation outcome quickly (-300 ms) after the shock. 
4:30 p.m. 
414-S Arterial Flow-Mediated Dilatation is Linearly 
Proportional to Vascular Wall Shear Stress: 
Endothelial Function Assessed by Phase-Contrast 
Magnetic Resonance Angiography 
Harry A. Silber, David A. Bluemke, Pamela Ouyang, Yiping P. Du, Joao 
AC. Lima. Johns Hopkins Medical Institutions, Baltimore, Mary/and, USA 
Background: Vascular endothelial function has been assessed noninva- 
sively by using ultrasound to measure flow-mediated dilatation (FMD) of the 
brachial artery. However, there is considerable overlap between the degree 
of dilatory response in arteries with normal endothelium and arteries with 
impaired endothelium, partly because FMD is related to baseline diameter. 
We sought to develop a more accurate noninvasive method of defining nor- 
mal endothelial function by investigating the mechanisms of FMD. Using 
phase-contrast magnetic resonance angiography, we quantified the relation 
between wall shear stress (WSS) and FMD in normal individuals. 
Methods: We studied 18 subjects, aged 25-46, without cardiac risk 
factors. With a blood pressure cuff and a 3 inch receiver coil on the upper 
arm, the c~lff was inflated above systolic pressure for 5 minutes. In a 1.5 
T magnet, scans were obtained before cuff inflation, immediately after cuff 
release (during peak hyperemia), and 1 minute after cuff release. Each scan 
was 15-25 seconds, ECG-gated, and gave 20 cardiac phases at a fixed 
plane perpendicular to the brachial artery. Systolic cross-sectional area, thus 
diameter (D), and spatially averaged systolic velocity (V) were calculated. 
For a blunted parabolic velocity profile and viscosity 0.0033 Pa-set, WSS = 
V/(30 D). 
Results: FMD, measured as percent,change in D at 1 minute post cuff 
release, was highly correlated with and linearly proportional to hyperemic 
WSS (r = 0.78, p = 0.0001). The results also explain why FMD in smaller 
arteries is greater than in larger arteries: 1) FMD is determined by hyperemic 
WSS. 2) WSS is proportional to V/D. 3) Baseline D does not determine 
hyperemic V (p = NS) but does determine hyperemic D (p < O.OOOl), so 
baseline D inversely determines hyperemic WSS (p = 0.048). 4) Therefore, 
FMD is inversely related to baseline D (p = 0.006). 
Conclusions: Using phase-contrast magnetic resonance angiography, 
we show for the first time that: 1) Flow-mediated dilatation in normal subjects 
is linearly proportional to hyperemic systolic wall shear stress. 2) FMD is 
greater in smaller arteries because the hyperemic wall shear stress created 
is greater in smaller arteries. In providing both diameter and wall shear stress, 
phase-contrast magnetic resonance angiography enhances the noninvasive 
assessment of vascular endothelial function, 
Results: 24 patients experienced a primary event of cardiac death (n = 
15) UNOS Status I head transplant (n = 3), or urgent implantation of a left 
ventricular assist device (n = 6). Doppler-derived dP/dt (dichotomized to > or 
~600 mm Hg/sec; p = 0.0002) and -dP/dt (trichotomized to ~450, 450650, 
and ~550 mm Hg/sec; p = 0.0001) predicted event-free survival, as did the 
combination of the two: 
Multivariable analysis revealed Doppler-derived risk groups, intravenous 
inotrope requirement, and BUN as significant independent predictors of out- 
come. 
Conclusion: New Doppler indices of dP/dt, -dP/dt, and risk groups 
defined by the combination of dP/dt and -dP/dt predict event-free survival in 
CHF. 
5300 p.m. 
414-5 Impact on Clinical Outcomes of Atrial Flutter in the 
Marshfield Epidemiologic Study Area (MESA) 
Juan Granada, William Uribe, Po-Huang Chyou, Mario Ortiz, Peter Smith, 
Param Sharma, John Hayes, Elaine Eaker, Humberto Vidaillet. A&&field 
Clinic, Marshfield, WI, USA 
Weaimed to determine the independent impact of atrial flutter (Afl) on clinical 
outcomes in the general population. MESA; a database that captures nearly 
all medical care among its 58,820 residents was used to identify all new cases 
of Afl. Toascertain its impact on adverse clinical outcomes (death and stroke), 
we used a representative sample in a prospective cohort study design and 
adjusted for 11 clinical variables. A total of 224 subjects were enrolled (112 Afl 
cases and controls). At 4 years of follow-up, adverse outcomes were present 
in 45 Afl cases (34 deaths and 11 non-fatal strokes) and 11 controls (9 deaths 
and 2 non-fatal strokes). Stroke-free survival was 60% in Afl versus 90% in 
the control group (P < O.OOOl).,After adjusting for all clinical variables, a 
multivariate analysis showed that patients with Afl were 4.3 times more likely 
to have a major adverse outcome than their controls (95%, Cl, 2.1 to 8.5). 
To exclude a potential contribution of concurrent atrial fibrillation on these 
outcomes, a separate multivariate analysis was performed in the 49 patients 
(44%) with only Afl. Patients who had only Afl, were 3.1 times more likely 
than controls to experience an adverse outcome (95%, Cl, 1 .I to 9.4). This 
study, a population-based study designed to determine the clinical course 
of Afl on the general population challenges prevailing beliefs regarding the 
prognosis of this condition. Our data suggest that Aft is associated with an 
increased risk of death or stroke similar to the previously reported for patients 
with nonvalvular atrial fibrillation. 
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El 414 4 New Doppler Indices of Left Ventricular Function to 
Anaheim Convention Center, Hall A 
Predict Survival in Congestive Heart Failure 
Presentation Hour: 9:00 a.m.-l 0:OO a.m. 
Theodore J. Kolias, Keith D. Aaronson, William F. Armstrong. University of 
Michigan, Ann Arbor, Ml, USA 
Background: Congestive heart failure (CHF) is associated with an increased 
risk of death or cardiac transplantation, yet techniques to predict survival are 
limited. The purpose of this study was to evaluate the ability of novel Doppler 
indices of left ventricular systolic and diastolic function to predict survival in 
CHF. 
Methods: Doppler-derived dP/dt and -dP/dt were determined prospec- 
tively from the continuous wave Doppler spectrum of the mitral regurgitation 
jet (dP/dt = 32/time between 1 and 3 misec; -dP/dt = 32/time between 3 and 
1 misec) in 56 patients with chronic CHF (age 60 + 15; LVEF 23 * 9%). 
1147-l 3 Adverse Cardiovascular Events Associated With 
the Use of Viagra 
Babak Azarbal, James Mirocha, Prediman K. Shah, Bojan Cercek, 
Sanjay Kaul. Cedars-Sinai Me&a/ Center, Los Angeles, California, USA 
Background: Viagra (sildenafil citrate) is an effective and the most commonly 
prescribed therapy for erectile dysfunction in men. However, there is limited 
safety data for Viagra, especially in patients with cardiovascular disease. 
Safety data for Viagra is derived mostly from retrospective subgroup analysis 
of phase ll/lll clinical studies in which patients with stable CAD represented 
<IO% of the total patients (n = 3700). 
Methods: Post-marketing adverse event reports (AERs) made to the 
FDA for Viagra from 4/15/98 until 5/21/99 were obtained under the Freedom 
of Information Act. All cases of death (D) and serious cardiovascular ad- 
verse events including myocardial infarction (Ml), sudden death/arrhythmia 
(SD/A), congestive heart failure (CHF), cerebrovascular accidents (CVA), 
and syncope/hypotension were selected for analysis. 
Results: There were a total of 1473 major adverse events reported after 
eliminating duplicate reports. Of these, D occurred in 522, MI in 517, SD/A 
in 255, CHF in 53, CVA in 119 and syncope/hypotension in 271 cases. The 
frequency of D, Ml or SD/A was 65% (956/1473) and that of D or Ml was 
57% (836/1473) of all major events. Of the 522 deaths, 200 were due to MI, 
94 to SD/A, 21 to CVA, 12 to CHF, 8 to syncope/hypotension and 187 due to 
unknown cause. Only 12% of all Viagra-associated deaths occurred in men 
who were using concomitant nitrates. However, in patients using concomitant 
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nitrates, D occurred in 68% (81/90) and D or MI in 88% (79/90). The age 
distribution was across all decades beginning in 3rd decade (mean age 61 
f 12). No identifiable cardiac risk factor was reported in 67% of the patients 
who died. Hypertension, diabetes and hyperlipidemia were reported in 28, 
IO and 7%, respectively. Two-thirds of deaths (44/67) occurred within 4-5 
hours of Viagra administration and most deaths (70%) were associated with 
the 50 mg dose. 
Conclusion: Data from the FDA’s post-marketing surveillance AERs 
show that there are a high number of deaths and serious cardiovascular 
events associated with Viagra. The majority of deaths are due to cardio- 
vascular causes, mostly occurring in patients ~65 years old without known 
cardiac risk factors. Most deaths are associated with standard Viagra dose 
and appear to be clustered around the time of dosing. Although concomitant 
.use of nitrates was associated with significant risk, most deaths occurred in 
patients not on concomitant nitrates. Further prospective randomized con- 
trolled trials are urgently needed to establish the safety of Viagra. 
1 1147-14 1 Quality of Life in Women With Chest Pain: The 
NHLBI-sponsored WISE Study 
Marian B. Olson, C. Noel Bairey Merz, Sheryl F. Kelsey, Diane Vido, 
Cheryl Rickens, Dawn Miller, Karen Matthews, Carol Cornell. University of 
Pittsburgh, Pittsburgh, Pennsylvania, USA 
Background: Previous work suggests that patients with chest pain experi- 
ence a decline in quality of life related to both severity and persistence of 
angina1 symptoms although this change has not been specifically described 
in women. 
Methods: WISE (Women’s lschemia Syndrome Evaluation) is a four 
center study of women who undergo coronary angiography for suspected 
ischemia. At the baseline visit, WISE evaluated 441 women (ages 27-88, 
median: 57 yrs.) in three domains of quality of life: general rating, func- 
tional capacity (Duke Activity Status Inventory (DASI)) and psychological 
state (Beck Depression Index (BDI)). The general rating is evaluated on a 
Liked-like scale ranging from 0 (worst) to IO (best). Ranges for the other 
scales are: Duke Activity Status Inventory: O-56.2 and Beck Depression In- 
dex (BDI): O-63. Higher DASI scores show greater functional capacity while 
higher BDI scores may indicate a greater severity of depression. 
Results: Overall neither the general rating, DASI, or BDI differed by type 
of angina (typical vs. atypical). However, after adjusting for age, younger 
women with atypical angina rated their quality of life lower (8.5) than younger 
women with typical angina (7.3) and older women with either type (7.4) (p 4 
0.002). There was no difference in the general rating or BDI by severity of 
CAD although functional capacity was lower in patients with ~50% stenosis 
in one or more arteries in comparison to groups with ~50% stenosis (22.6 
vs. 18.5 respectively, p = 0.02). In general, more frequent chest pain was 
, associated with a lower general rating and DASI and higher scores for the 
BDI. Women who reported never having had chest pain within the last six 
weeks had the best quality of life scores in the general rating (8.1) and 
BDI (5.9) and among the best for the DASI (23.4) compared to women who 
reported having pain daily: general rating (6.4) BDI (11.2) and DASI (15.5) 
(p < 0.001, p 4 0.01, p < 0.003, respectively). 
Conclusions’: In this cohort of WISE women undergoing coronary an- 
giography a lower quality of life rating is not associated with greater severity 
of CAD but is associated with atypical angina in younger women and with 
increased frequency of chest pain symptoms in all women. 
1 1147-l 5 1 is the Quality of Care in Octogenarians With 
Acute Myocardiai infarction Optimal? 
Rajendra H. Mehta, Erik J. Stalhandske, Patricia A. McCargar, 
Pamela Russman, Thomas Ruane, Kim A. Eagle. Center for Health 
Outcomes and Evaluation, Plymouth and University of Michigan Heart Care 
Program, Ann Arbo,: Michigan, USA 
Background: Few data exists addressing the process of care in the ‘very 
old’ (octogenarians) with acute MI (AMI). Since increasing age is associated 
with poor outcomes after AMI, quality of care in this high-risk subset is of 
great interest. 
Methods: To evaluate quality of care in octogenarians with AMI, we 
analyzed data from the Cooperative Cardiovascular Project in Michigan. 
Quality of care indicators were compared for patients ~80 yrs to those ~80 
yrs using standard statistical methods (p < 0.002 considered as significant 
to account for multiple comparison). 
Results: Octogenarians were more frequently females with non-Q AMI 
but less likely to have diabetes, prior PTCA, or prior CABG as compared to 
those ~80 yrs. Invasive procedures were less frequently used for the very 
old. As compared to ‘younger patients’, octogenarians had higher 30 day 
mortality (14.5% vs 28.3%, p < 0.001). Adherence to key quality indicators 
is as shown in the table. 
”  Median aae ReDerfusion DC ACE inhibitors 
Age ? 80 “rs 2447 84 “rs 
512 hrs 
30.4% 
for EF <35% 
63% 
Age =Z 80 ;rs 6006 71 ;‘s 70.2% 61% 
P value - <O.OOl 0.53 
DC DC beta- No calcium- Smoking cessation 
ASA blockers blockers counseling 
Age > 80 yrs 80.2 53 90.1 28 
Aae < 80 “IS 80 
Pialue ’ 
57 89 37 
0.90 0.37 0.76 0.04 
Conclusions: Octogenarians received repetfusion therapy less frequently 
as compared to ‘younger’ patients. Adherence to other key quality indicators 
was similar for the two groups. Atypical presentation at the time of MI or fear 
of more complications in the very old may have accounted for the less fre- 
quent use of reperfusion therapy. Further education of physicians addressing 
the benefits of reperfusion therapy in this group of high-risk patients may be 
helpful in increasing the use of this beneficial therapy for such patients. 
I Disease 
1147-l 6 Quality of Life With End-Stage Coronary Artery 
David E. Kandzari, La Choi Lam, Eric L. Eisenstein, 
Nancy Clapp-Channing, Daniel B. Mark, James G. Jollis. Duke Clinical 
Research Institute, Durham, NC, USA 
Background: As patients with end-stage coronary disease [ESCD] are rou- 
tinely excluded from clinical trials of coronary revascularization, their natural 
history remains poorly defined. 
Methods: Patients with ESCD [n = 4871, defined as three vessel or left 
main coronary disease and reduced left ventricular ejection fraction or severe 
angina not treated with revascularization within 30 days of catheterization 
[mean age 67,33% female, 50% prior revascularization], were compared to a 
reference population with similar clinical characteristics receiving angioplasty 
[P;n = 1251 or bypass surgery [C;n = 5771. Functional status and quality of 
life were prospectively followed [median 2.2 years] using the Short Form 36, 
Duke Activity Status Index [DASI] and Rose Angina Questionnaire. To control 
for the tendency of higher mortality among less functional patients, functional 
status measures for the subset of patients who survived to complete all 
questionnaires were also compared. 
Results: Mortality was exceedingly high for the ESCD cohort [ESCD-38%, 
P-15%, C-19%, p < O.OOi]. Measures of general health perception did not 
significantly change during follow up, while measures of physical functioning 
and bodily pain improved for all groups including patients who did not un- 
dergo revascularization [DASI, p < 0.007; angina, p < O.OOl]. Measures of 
functional status for patients not surviving were similar and could not account 
for the improvement among ESCD patients. 
Badne 1 year *year 
t p=NS; II pCO.04 
/ Conclusion: Remarkably, most measures of functional status and quality 
of life among patients with end-stage coronary disease did not differ from 
patients treated with coronary revascularization, despite significantly greater 
disease burden and mortality. These findings indicate that widely employed 
measures of general health perception exhibit some independence from 
underlying illness, and also suggest measures that may be employed in trials 
of new therapies for ESCD. 
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1503-l Secure and Accessible Electronic Medical 
Records: Setting Up Your Own Reliable, Low-Cost 
Web-Based System 
L.E. Widman’ , D.A. Tong”. ‘U. Texas HSC;‘Southwest Research Institute, 
San Antonio, TX, USA 
Introduction: Medical records are often required at multiple sites, but secure 
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data transmission has been problematic for many providers and organiza- 
tions. We describe a practical method for using readily available, inexpensive 
software components to build a electronic medical record system that is ac- 
cessed securely via the World Wide Web. 
Methods: We assumed a degree of computer expertise that is now com- 
monly available among advanced high school students. Three components 
are required: a secure Web server; a database server; and a server-side 
Web script interpreter. To ensure low cost and reliable high quality, we se- 
lected open-source components: Apache web server (wwtv.apache.org) with 
the Raven security module (wwwcovalentnet), the MySQL database server 
(www.fcx.se) and the PHP interpreter (www.pbp.nef) running under the in- 
creasingly popular Linux operating system on ordinary IBM PC-compatible 
hardware. 
The Raven module costs $357. The other software is available with no- 
cost licenses. Because the software improves rapidly with updates every 
few months, the latest versions were used. A less expensive secure server 
is available from www.redhatcom for $150. Equivalent Microsoft software 
(www.microsoft.com); that may be less secure (wwwxertorg), costs at least 
$3,000. The medical records can be viewed with any browser capable of se- 
cure protocols, such as Netscape and Internet Explorer, using any operating 
system (e.g., Windows, Unix). 
Results: After installation of the individual software components, the 
following steps were required: (1) generating a secure Server Certificate 
using the software, (2) writing the scripts that implement the user interface to 
the database, and (3) creating the database structure and initializing it from 
preexisting data. The Clinical Electrophysiology Service at UTHSCSA has 
used this system routinely since 12/97. 
Conclusion: Secure, Web-based electronic medical record systems can 
be implemented using inexpensive software that is available both in open- 
source and in commercially supported forms. We have demonstrated how to 
implement such a system at a software cost of less than $500. The resulting 
system can supporl practices ranging in size from individuals to multi-institu- 
tional groups. 
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1171-l 3 Impact of Quality Improvement Initiative on Long 
Term Compliance to Key Quality of Care 
Indicators After Acute Myocardial Infarction 
Ashish Gupta, Marci Plante, Dean Karavite, Pamela Russman, 
David Bruckman, Kim A. Eagle, Rajendra H. Mehta. University of Michigan 
Heart Care Program, Ann Arbor, Michigan, USA 
Background: Several studies have shown that quality improvement initia- 
tives are successful in improving quality of care for patients with acute MI. 
However, the long term impact of quality of care initiatives in continuing 
adherence to key indicators is unknown. 
Methods: To evaluate the impact of quality improvement initiative on long 
term adherence to quality indicators, we attempted to survey all patients with 
acute MI discharged alive from our hospital in 1997 (n = 199). A telephone 
survey was conducted to determine adherence to key indicators including 
medications [betablockers (BB), angiotensin converting enzyme inhibitors 
(ACEI), lipid lowering agents (LLA), aspirin (ASA)]; participation in rehabili- 
tation or regular physical activity; and compliance with tow fat and smoking 
cessation. 
Results: With aggressive attempts, 1601199 patients were contacted, 
of whom 16 were deceased. Of the surviving 144 patients (mean age = 
62 years) contacted, 72.2% were male. Adherence to key quality of care 
indicators are shown in the table below. 
The VA’s Multimedia Hospital Workstation With 
Text, Images and Cine, A Cardiologist Looks at 
Telemedicine 
Ross D. Fletcher, Ruth E. Dayhoff, Amanda C. Graves, Stuart Frank, Chiao 
M. Wu, Elsie Casugay, Kevin Crawford, Christopher McManus, Ronald 
E. Jones. Department of Veterans Affairs and Georgetown University 
Medical Centers, Washington, DC, USA 
Background: Our goal at the Washington VA Medical Center is to provide an 
electronic, paperless, multimedia patient record, which is available through- 
out the hospital. The system gives the Cardiologist, and other caregivers, an 
easy to use GUI based patient chart, all diagnostic images, tine loops, and 
ECGs. The electronic patient record is available at over 900 workstations 
and remotely as well. 
System: The VA has installed a distributed network to manage all as- 
pects of the clinical record. The system was built with standard off-the-shelf 
components. Capture stations collect images, which are saved to a jukebox 
and linked to the patients textual information contained in a legacy database. 
A 1 -gigabyte fiber optic backbone distributes information to the data closet 
where a lO/lOO-Megabyte link brings it to the desktop. Thus, the timely deliv- 
ery of large image files such as X-rays, Cat scans, MRls, and Cineangiograms 
is ensured. Workstation software includes Windows NT 4.0, the VA VISTA, 
CPRS, and Imaging software, Internet Explorer, and MS Office Professional. 
Cardiology images such as echoes, coronary arteriograms, ventriculograms, 
MUGA, thallium studies, X-rays, and ECG tracings, as well as multispe- 
cialty images from Oncology, Radiology, Surgery, Dentistry, Endoscopy, and 
Pathology, to name a few, are available. The Cardiology database includes 
records of over 6,134 Caths; 6,933 Holters; 73,052 ECGs; 19,412 Echocar- 
diograms; 9,360 ETTs; and 1,613 EPs. 
Results: Since all notes, orders, and progress reports are written directly 
into the workstation, there has been a marked reduction in transcription 
services for catheterization reports and discharge summaries. The number 
of delinquent charts has been cut in half. The latest lab values can be 
compared to the oldest and plotted. Diagnostic images are available with the 
chart at any point of care. Patient education is improved since the diagnostic 
image can be explained in the doctor’s office. Reference materials such as 
the electronic PDR, Medline searches, and library reprint requests are also 
a click away on the Medical Service web site. 
Conclusions: The electronic patient record can be run in any setting 
from a single laptop to small and large networks, providing timely and com- 
plete patient information at the point of care, and in offices, conference and 
procedure rooms. Clinicians have a tool that provides complete Cardiologic 
and other patient information, which enhances their productivity and helps 
provide better and more complete patient care. 
Drugs 
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Follow-up 
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Conclusion: Despite a high level of adherence to key quality indica- 
tors at discharge, long term adherence to BB and ACEI declined. Significant 
opportunities also remain for smoking cessation counseling and dietary modi- 
fication. Lipid lowering therapy compliance increased significantly suggesting 
an appropriate re-evaluation during follow-up. Further methods need to be 
designed to improve long term adherence. 
I 1171 14 Amlodipine Reduces Cost of Inpatient Care Associated With Treatment of Cardiovascular 
Diseases in Patients With Clinical Coronary Artery 
Disease 
G. John Chen, Robert P. Byington, William P. Moran. Deparfments of Public 
Health Sciences and Infernal Medicine, Wake Forest Universify School of 
Medicine, Winston-Salem, North Carolina, USA 
Background: We examined whether amlodipine can reduce direct cost of 
inpatient care associated with treatment of cardiovascular disease (CVD) in 
patients with angiographic evidence of coronary artery disease from a third 
party payer perspective. 
Methods: We used clinical data derived from the Prospective Random- 
ized Evaluation of Vascular Effects of Norvasc Trial (PREVENT). PREVENT 
was a 3-year, randomized, masked, placebo-controlled, multicenter, clini- 
cal trial originally designed to test the antiatherogenic effect of the calcium 
channel blocker amlodipine in 825 patients with coronary artey disease 
(417 patients for amlodipine and 408 patients for placebo). The clinical CVD 
events included congestive heart failure (CHF), myocardial infarction (Ml), 
stroke, angina, coronary artery bypass graft (CABG), percutaneous coronary 
angioplasty (PTCA), stent placement, athrectomy, valve replacement, and 
catheterization. The unit costs measured by charges for these CVD events 
were assigned in dollar values, respectively, based on the financial data 
from Healthcare Cost and Utilization Project (HCUP-3). The annual cost of 
amlodipine per patient (IO mg, q.d.) was based on the Red Book 1997. All 
charges were adjusted to 1997 U.S. dollars. 
Results: The net number of clinical CVD events averted was 27.9 per 
100 patients in the amlodipine patient group over three years. In the same 
time period, the total net saving associated with the averted CVD events in 
inpatient care in the amlodipine group was estimated at $426,462. The net 
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saving of inpatient care in the amlodipine group relative to the placebo group 
was averaged at $628 per patient per year. 
Conclusion: In this study, amlodipine is found to be a cost-saving agent 
in treatment of patients with clinical coronary artery disease relative to the 
placebo. Use of amlodipine can reduce costs of inpatient care associated 
with CVD. 
[1171-15/ Reduction in Mortality With Aggressive Multiple 
Risk Factor Interventions in Younger Patients 
With Symptomatic Coronary Artery Disease 
Kevin J. Graham, Laura Johnsrud, Barry Welge, Faye Bullemer, 
Susan White, Therese Meszaros, Krista Stenhaug, David Friend, 
Jill Hershberger, Ford W. Bell. Minneapolis Heart lnsfifub Foundation, 
Minneapolis, Minnesota, USA 
Background: Few studies exist on the impact of aggressive secondary 
prevention addressing multiple risk factors in younger patients with known 
coronary artery disease. 
Methods: 2,060 consecutive hospitalized patients (pts) with symptomatic 
coronary artery disease (CAD) were entered over 6 years from 1992 to 
3998 into the Minneapolis Heart Institute Foundation (MHIF) “55 and Under 
Registry”. Baseline risk factors, diagnostics and interventions, medications 
and pts’ perceptions were recorded. All pts were offered 3 month and yearly 
preventive follow-up. Aggressive Multiple Risk Factor Intervention (AMRFI) 
was provided for dyslipidemia, hyperhomocysteinemia, CHF, hypertension, 
and diabetes focusing on diet, exercise, appropriate drug therapies, and 
antioxidant and other vitamin regimens. Complete follow-up was obtained on 
99.6% of pts. 
Results: A total of 994 pts returned for AMRFI and 1,070 selected usual 
care (UC). Baseline data predicting usual care (UC) over AMRFI were: active 
smoking (p = 0.001) and driving distance from MHIF (p = 0.001); AMRFI over 
UC was: father with dyslipidemia (p = 0.04). Total Mortality (average 44.7 
months post hospital discharge) was UC = 55 pts (5.1%), AMRFI. = 19 pts 
(1.2%); p < 0.001. Annual Mortality was UC = 1.4% and AMRFI = 0.3% (p < 
0.001). 
# of pts 
Mortality 
Annual Mortality 
UC 
1,070 
55 
1.4% 
AMRFI 
914 
19 
0.3% 
P= 
<O.OOi 
<O.OOi 
Conclusions: AMRFI in younger pts with symptomatic CAD led to a 77% 
decrease in annual mortality vs. patients with UC. Widespread implementa- 
tion of AMRFI could lead to striking decreases in mortality in younger pts with 
CAD. 
1171-I 6 Disease Management Program Improves Care of 
Patients Hospitalized With Congestive Heart 
Failure 
Carla A. Sueta, Julie B. Price, Kelly C. Manix, Sandra L. Jarr, Johnnie 
B. Hamm, Elizabeth Arsenault. University of North Carolina, Chapel /-/ill, 
AC, USA 
Background: Guideline-based management of patients with heart failure 
(CHF) remains suboptimal. We investigated whether adopting a disease 
management program would improve the care of patients hospitalized with 
CHF. 
Methods: A multidisciplinary team at the University of North Carolina 
Hospitals developed an inpatient CHF Disease Management Program that 
included: pre-printed physician orders, a literature resource binder, nursing 
care plan, home discharge instructions, and patient education materials. We 
targeted 5 care indicators (table) and reviewed 98 charts prior to implement- 
ing the program (baseline). After implementation, we abstracted the charts 
of 101 patients enrolled in the program (on pilot) as well as the charts of 31 
patients who were not enrolled (not on pilot). 
N 
Age (Y=) 
Women 
African American 
Hx CHF 
Care Indicators 
LV assessment 
Discharge on ACE-I 
Sodium restriction 
Daily weights 
Follow up 
Baseline 
98 
65.1 
48% 
37% 
53% 
75% 
73% 
54% 
22% 
45% 
Not on pilot 
31 
58.9 
32% 
29% 
52% 
90% 
88% 
74% 
32% 
39% 
Pilot 
101 
64.1 
44% 
40% 
75% 
97%’ 
93%’ 
87%* 
57%* 
56%’ 
Results: There was significant improvement in all 5 care indicators be- 
tween baseline vs pilot and not on pilot vs pilot, ‘p < 0.05. In on-pilot patients 
? 65 years of age, there was a significant decrease in 30-day readmissions. 
Conclusion: Our results suggest that a systems approach can substan- 
tially improve the care of patients hospitalized with CHF. 
infoQACC 
11504[ Computer Applications: Expert Systems and 
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Tuesday, March 14, 2000, I:30 p.m.-500 p.m. 
Anaheim Convention Center, ACC Central, Hall D 
) 1504-l 1 Acute Myocardial Infarction Morbidity After 
Previous Revascularization: Prediction Using 
Neural Networks 
Mitrovic M. Predrag, Stojanovski S. Goran’, Vasiljevic Zorana, 
Stefanovic Branislav, Perunicic Jovan, Mrdovic Igor, Matic Gordana, 
Rajic Dubravka, Jozic Tanja; Milentijevic Biljana. Cardiology Clinic, lnstitote 
for Cardiovascular Diseases, Clinical Centel; Belgrade; ‘Electrical 
Engineering, Faculty in Be/grade, Yugoslavia 
Background: Neural networks are nonparametric, robust, pattern recogni- 
tion techniques that can be used to model complex relationships. This study 
sought to assess the usefulness and accuracy of artificial neural networks 
in the prognosis of 8-year acute myocardial infarction (AMI) morbidity after 
previous coronary artery bypass surgery (CABS). 
Methods: Seven hundred and eighty patients (pts) with AMI after previ- 
ous CABS were used as database to assess the applicability of multilayer 
perceptron neural network (MLP) to AMI morbidity after previous CABS. The 
results of traditional logistic regression and Bayesian analysis were com- 
pared with single-layer (no hidden layer), two-layer (one hidden layer) and 
three-layer (two hidden layer) MLP neural network. All prediction models 
used the same variables and were evaluated by training on 420 pts and 
cross-validation testing on a separated group of of 360 pts. Techniques were 
also developed to calculate effective odds ratios for MLP networks and to 
generate confidence intervals for MLP risk predictions using an auxiliary 
“confidence MLP”. 
Results: For all classifiers, including neural networks, receiver operating 
characteristic curve areas for predicting AMI morbidity after previous CABS 
was approximately 74%. Accuracy of posterior probability prediction was 
slightly better with a two-member committee classifier that averaged the out- 
puts of a MLP network and a logistic regression model. Unlike the individual 
methods, the committee classifier did not overestimate or underestimate risk 
for high-risk pts. 
Conclusion: A committee classifier combining the best neural network 
and logistic regression provided the best model accuracy of posterior proba- 
bility prediction, but the receiver operating characteristic curve area was only 
74% irrespective of which predictive model was used. 
1504-2 CVRisk: A Coronary Heart Disease Risk 
Calculator-Advisor 
Felix A. Vergara, Georgi Kostov. 7’P/, Temple University: Philadelphia, 
Pennsylvania; CBIL, Univ. of Pennsylvania, Philadelphia, Pennsylvania, USA 
Introduction: The Framingham Heat-l Study Group (FHSG) has published 
several multivariable formulas and charts that permit the calculation of the 
coronary heart disease (CHD) risk. The aim of this report is to present a 
computer program that calculates the CHD risk, and prints a customized 
handout based on the data (risk factors) entered. 
Material: The algorithm is based on the formulas published by the FHSG 
in the 1990 and 1991 articles. Visual Basic 6.0 Professional Edition was used 
to develop the computer program. 
Software: The software consists of two “forms.” The first “form” is for data 
acquisition. It has “textboxes” to enter the continuous data (age, systolic blood 
pressure, total cholesterol, and high-density lipoprotein). It also has “radio 
buttons” to select the appropriate qualitative data (gender, smoking habit, 
left ventricular hypertrophy by EGG, and diabetes mellitus). Finally it has a 
“textbox” to enter the period of years for the risk estimation. The second “form” 
shows the risk calculation results. It has three columns: “risk,” “minimum 
risk,” and “risk ratio.” The rows are the calculated risk (in percentage) of 
CHD, myocardial infarction, CHD death, stroke, cardiovascular disease, and 
cardiovascular death, as described in the articles. The “form” has a “button” 
to print the handout, which is a two-page report. The first page has the 
patients risk profile. The second page contains information on each of the 
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risk factors that contributes to the patient’s CHD risk. If the patient’s risk 
is equal to, or less than the “minimum risk,” a congratulations message is 
printed. If the patient’s risk is higher than the “minimum risk,” an appropriate 
message, based on the variables that are increasing it, is printed. There 
are comments on smoking habit, elevated cholesterol, low HDL cholesterol, 
hypertension, diabetes mellitus, and presence of left ventricular hypettrophy 
on the electrocardiogram. 
Comments: The software was developed to serve the needs of physi- 
cians and patients. The former have very limited time to calculate the risk and 
explain its meaning to the patient. The latter frequently has limited knowledge 
about CHD risk factors. A personalized handout might help promote lifestyle 
modifications and compliance. Another possible advantage of a computer 
program is that the data can be entered in the computer program by the 
patient while in the waiting room, or at his or her home via the Internet. 
POSTER 
1 1193 ] Outcomes in Coronary Treatment: PTCA and 
Antiplatelet Drugs 
Tuesday, March 14, 2000,3:00 p.m.-500 p.m. 
Anaheim Convention Center, Hall A 
Presentation Hour: 3:00 p.m.-4:OO p.m. 
1193-l 3 Expert Rating of Angioplasty in Europe 
Willibald Maier’ , Manfred B. Wischnewsky*, Bernhard Meier’ On Behalf of 
the AQUA Study Group; ’ Cardiology Universify Hospital Bern, Switzerland; 
‘Center for Computing Technology, University Bremen, Germany 
Purpose: The working group Coronary Circulation of the ESC has mandated 
a study on appropriateness, necessity, and performance of coronary angiog- 
raphy (cath.) and PTCA in Europe (AQUA trial = Audit and quality control in 
angioplasty). The cases were to be subjected to an expert rating. 
Methods: From the countries participating in the European Registry of 
Coronary Interventions, the 3 countries with the highest absolute PTCA 
volume (Germany, France, and the United Kingdom) and 2 randomly selected 
countries (Belgium and Italy) have been chosen for investigation. In these 
countries, 5 centers have been selected at random according to the following 
criteria: 1 center performing >lOOO procedures/year, 3 centers of 300-1000 
procedures/year and 1 center of 1300 procedures/year. In each of these, IO 
cases of the first half of 1997 have been randomly identified. A panel of four 
to eight experts performed a blinded rating of all pertinent material. 
Results: In 250 cases (male 82%; mean age 63; multivessel disease 
58%; target lesions/intervention 1.3; stenting 49% of target lesions) appro- 
priateness and necessity were according to panel majority (? = uncertain): 
Yes NO 7 lnallff data 
Appropriateness of diagnostic cath., % 68 0 6 6 
Necessity of diagnostic c&h., % 82 11 7 0 
Appropriateness of PTCA, % 78 7 10 4 
Necessity of PTCA, % 61 24 13 2 
Performance parameters of procedures (technique of the operator, op- 
arator assessment of target lesions, stenting policy, procedural and overall 
success) were also subjected to expert rating. Analysis per country and 
center volume showed no severe differences between countries, but a signif- 
icantly better performance and higher inclination to stenting in high volume 
centers. However, considerable intra- and interobserver variabilities of the 
expert ratings were found. 
Conclusion: Based on scrutinized hospital and operator data, the AQUA 
study reveals a satisfactorily high percentage of justified indications as docu- 
mented by the portion of procedures rated as appropriate, albeit not invariably 
necessary. The variability in the judgement of expert auditors reflects clinical 
reality. 
1193-l 4 A Simple Mortality Risk Prediction Tool for 
Individual Patients Undercloina Percutaneous 
Coronary Interventions: iReport From the Blue 
Cross/Blue Shield of Michigan Cardiovascular 
Consortium (BMCS) 
Mauro Moscucci, David Share, Michael J. O’Donnell, Ann Maxwell-Eward, 
James L. Chambers, William L. Meengs, Phillip Kraft, Eva Kline-Rogers, 
Kirit Patel, John McGinnity, Kim Eagle. University of Michigan Coordinating 
Center, BMCZ Group, Ann Arbor, Michigan, USA 
Risk adjustment models for PCI mortality have been proposed and used for 
comparison of operator specific outcomes, but their application in predicting 
individual patient outcomes is untested. 
Methods: Data were prospectively collected from 7,557 PCI in a con- 
sortium of 7 hospitals. Predictors of in hospital death were identified using 
logistic regression. A scoring system was developed on the basis of the 
regression model, and the total score for individual patients was calculated. 
Results: In this large cohort, the overall in-hospital mortality was 1.6%. 
Independent predictors of death and the weighted scores are listed in the 
formula below. As shown in the figure, there was a near perfect correlation 
between the total score and the observed mortality, with increasing scores 
associated with higher mortality rates (p < 0.01). 
Score = (1.5 * Ml) + (2.0 * Shock) + (Creatinine > 2 * 2.0) + (1.5 * Hx 
cardiac arrest) + (0.5 l # diseased vessels) + (1 * age > 70) + (0.5 * ef < 
50%) + (0.5 * pvd) + (0.5 * Female gender) 
Conclusions: Accurate predictions of patient specific prognosis can be 
obtained using a simple prediction rule. These predictions could be used 
when discussing with patients’risks and prognosis of PCI. 
\ 1193-i 5 ) Do Patients Undergoing Multivessel Interventions 
Have Worse Acute and Long Term Outcomes? 
Julian M. Esteban, Achamyeleh Gabremariam, Kathi Harris, Eva 
M. Kline-Rogers, Pam L. Russman, Kim A. Eagle, Mauro Moscucci. 
University of Michigan, Ann Arbo,r, Michigan, USA 
Background: Recent studies have shown that muitivessel percutaneous 
interventions (MPI) can be performed with favorable clinical outcomes. How- 
ever, most of these studies have focused on selected patients populations 
and have excluded patients with acute myocardial infarction (AMI), cardio- 
genie shock and prior CABG. Little is known regarding acute and long-term 
outcomes of unselected patients undergoing MPI. 
Methods: Baseline characteristics and clinical outcomes of 260 consec- 
utive patients undergoing interventions in 2 or more coronary arteries, and of 
1115 consecutive patients undergoing single vessel interventions were com- 
pared. The overall patient population was a high-risk group characterized by 
a high incidence of acute myocardial infarction (14%) and cardiogenic shock 
(3%). In hospital and long term mortality, and a combined end-point including 
repeat percutaneous intervention, coronary bypass surgery, acute myocar- 
dial infarction (AMI) and death were evaluated using multivariate logistic 
regression analysis. 
Results: Baseline patients and lesions characteristics, and in hospital 
mortality were similar between the two groups. There were no significant 
differences in the incidence of the combined 1 year end point (25.7% vs. 
26%), while the overall 1 year mortality rate was significantly higher for MVI 
(15% vs. 9.2%, p = 0.017). However, after adjustment for comorbidities, MVI 
was not a predictor of worse 1 year survival, or of worse 1 year combined 
outcome. 
Conclusion: In an unselected, high-risk patient population, multivessel 
interventions and single vessel interventions are associated with similar acute 
and long-term outcomes. 
1193-I 6 Rehospitalization: An Outcome That Parallels 
Other Major Erndpoints in Comparisons of 
Antiplatelet Therapy 
Deepak L. Bhatt, Derek P. Chew, Fernando A. Cura, Eric J. Topoi. 
C/eve/and Clinic, Cleveland, Ohio, USA 
Background: Rehospitalization for recurrent ischemic events or bleeding 
is common in patients with atherosclerosis who are being treated with an- 
tiplatelet agents. We sought to determine whether this outcome was con- 
cordant with “hard” endpoints, such as death or Ml, in two major trials of 
antiplatelet therapies. 
Methods: The rates of rehospitalization were determined for the 19,185 
patients randomized to either clopidogrel or aspirin in the CAPRIE study and 
for the 9,169 patients randomized to aspirin, low dose or high dose sibrafiban 
in the SYMPHONY trial. These rates were compared with the main endpoints 
of the trial. 
Results: The rate of death or Ml at 90 days in SYMPHONY was 7.0% 
in the aspirin arm and 7.7% in the combined sibrafiban arms. The rate 
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of vascular death, MI, and stroke per year in CAPRIE was 5.8% in the 
aspirin arm and 5.3% in the clopidogrel arm. The figures above show that 
rehospitalization tracks well with the main endpoints of the trials. 
y. 10 20 30 40 50 60 70 80 90 
Days from Treatment Start 
o- 
a 5 10 15 zn 26 30 35 
Months fromTreatment Start 
Conclusion: Both large trials of antiplatelet therapies show the remark- 
able consistency of rehospitalization as an endpoint compared with more 
traditional outcome measures. 
ORAL 
I 895 Implementing Tools to Improve 
Caidiovascular Care 
Tuesday, March 14, 2000,4:00 p.m.-%00 p.m. 
Anaheim Marriott, Marquis Northwest 
4:00 p.m. 
895-l A Trial to Improve Compliance With National 
Cholesterol Education Program Guidelines 
Audrey H. Wu, Thomas T. Tsai, Pamela L. Russman, Kim A. Eagle, Steven 
J. Bernstein. University of Michigan, Ann Arbor, Michigan, USA 
Background: Our purpose was to assess the efficacy of computer-generated 
patient-specific reminders in improving compliance with National Cholesterol 
Education Program (NCEP) guidelines for managing hyperlipidemia. 
Methods: Appointments between June 1 and August 31, 1998 (baseline 
period) and October 27, 1998 and January 29, 1999 (reminder period) at two 
university outpatient clinics were reviewed. Eligible patients had total choles- 
terol >200 mg/dL or low-density lipoprotein cholesterol 2130 mg/dL, within 
the preceding 2 years. One clinic was randomly selected for intervention. 
During the baseline period, routine care at both clinics was observed. During 
the reminder period, chart reminders listing the patient’s lipid values for the 
past 2 years were placed at the intervention clinic. 
Results: Final analysis included 2888 visits. Screening compliance im- 
proved from 74.1% to 80.8% (p = 0.01) at the intervention clinic; no sig 
nificant change was observed at the control clinic (73.0% to 76.6%; p = 
0.24). There were no significant changes In treatment compliance at either 
clinic. Treatment compliance for patients without coronary artery disease 
(CAD) was lower (range 50.9%58.6%) than for patients with CAD (range 
71.9%-83.7%). In multivariate models for screening and treatment compli- 
ance, there was no significant effect of study period, clinic, or interaction 
between period and clinic. 
Conclusion: Overall, screening compliance was high, while treatment 
compliance was sub-optimal. Treatment compliance was lower for primay 
prevention of CAD than for secondary prevention. We found only a lim- 
ited effect of providing patient-specific reminders on compliance with NCEP 
guidelines. 
4:15 p.m. 
895-2 Development and Testing of a Clinically-Detailed 
Tool to Assess Quality of Care in Hypertension 
Anandi V. Law, Pablo Lapuerta, Steven M. Asch. RAND Health, Santa 
Monica, CA; Pharmaceutical Research Institute, Bristol-Myers Squibb, 
Princeton, N& RAND Health, Santa Monica, CA; West Los Angeles 
Veterans Administration, West Los Angeles, CA, USA 
Background: Guidelines for care of hypertensive patients have prolifer- 
ated recently, yet quality assessment remains difficult in the absence of 
well-defined measurement tools. As part of a larger effort, we developed 
indicators for measuring process quality in hypertension. We tested this tool 
on hypertensive women. 
Methods: We selected indicators based on the explicit a priori criteria 
of clinical importance, outcome link, evidence strength, operational ease, 
provider accountability, reliability and adaptability. A 1996 expert panel rated 
the indicators using the modified Delphi method. 1 screening, 4 diagnostic, 
5 treatment, and 3 follow-up indicators survived this process. 
Data Collection: Trained nurses used a laptop-based tool to abstract data 
from medical and administrative records on patients from 1 staff model and 
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1 independent practice arrangement health plan who had visits in 1996-7. 
For the screening indicator, 467 adult women under 50 were evaluated; 234 
women under 65 with average blood pressure (BP) > 140/90 or a documented 
diagnosis of hypertension were evaluated for the remaining indicators. 
Results: We analyzed the 12 non-screening indicators and calculated 
preliminay unweighted adherence proportions for each. Ninety-seven% of 
patients were eligible for at least 1 indicator. For the 12 indicators, eligibility 
varied from 0.4% to 96%, failure rates varied from 20% to 100%. For example, 
6/30 (20%) of documented newly diagnosed hypertensives did not have 3 
BP’s 2 140/90. Of 112 patients with persistent BP p 160/90, 57 (51%) did 
not receive a change in therapy or repeated lifestyle modification. 
Conclusion: Quality of hypertensive care fell short of indicators based on 
national guidelines. The data suggest that physicians may not be sufficiently 
aggressive in their approach to the treatment of hypertension. 
4:30 p.m. 
895-3 Oral Amiodarone Prophylaxis and a Clinical Pathway 
Approach to Atrial Fibrillation Following Primary 
Coronary Artery Bypass Graft Surgery: Preliminary 
Results of Phase II of the Postoperatfve Atrial 
Fibrillation in Cardiac Surgery Study 
Michael H. Kim, William Rachwal’, Carol McHale’, David Bruckman, 
Pamela Russman, Fred Morady, Kim Eagle. University of Michigan, Ann 
Arbor, Michigan; ’ Toledo Hospital, Toledo, Ohio, USA 
Postoperative (postop) atrial fibrillation (AF) is the most common complica- 
tion following cardiac surgey and is associated with an increase in length 
of stay (LOS). Wide practice variations exist in its management. A clinical 
pathway was implemented using oral amiodarone prophylaxis either preop- 
eratively (preop) (200 mg tid for 7 days, then 200 mg qd until discharge) or 
immediately postop (600 mg tid for 3 days, then 200 mg qd until discharge), 
early identification of AF, rate and rhythm control, and anticoagulation. Pa- 
tients (pts) undergoing primary coronary artery bypass graft surgery and in 
sinus rhythm preop were eligible. 77 consecutive pts were identified prior 
to pathway implementation (PI) and analyzed as controls. 71 consecutive 
pathway pts were prospectively followed after PI. There ,were no major differ- 
ences in preop demographic and clinical variables or rates of treatment with 
beta-blockers either preop or postop. In the prospective group, amiodarone 
was given preop in 14% and postop in 79% (none in 7%). Amiodarone was 
not used as prophylaxis in the control group. The clinical pathway was used 
effectively in 83% of the prospective group. Amiodarone prophylaxis and PI 
were associated with a significant reduction in postop AF (9.9% vs 27.6%; p 
= 0.01). Preop and postop amiodarone prophylaxis were equally effective in 
preventing AF. Median LOS were 6 and 7 days for the control and prospective 
groups, respectively (p = 0.17). 
Conclusions: (1) Oral amiodarone prophylaxis, including immediately 
postop, is effective in reducing postop AF, (2) despite a reduction in postop 
AF, no effect on LOS is seen with the use of a clinical pathway. 
4:45 p.m. 
895-4 Advanced Heart Failure Shared Clinical Experience 
Network IAHF SCENE) Educational Program 
ImprovesClinical and-Economic Outcomes 
Hector 0. Ventura, lleana Piria. Tulane University Medical Center, New 
Orleans, Louisiana; Temple University School of Medicine Philadelphia, 
Pennsylvania, USA 
Background: AHF SCENE teaches a multidisciplinary approach to AHF 
treatment, emphasizing establishment of HF clinics and guidelines, more 
aggressive medical therapy, integration of emergency room (ER) to HF care, 
and tracking outcomes. 
Methods: To assess the impact of AHF SCENE as an educational 
tool, participants representing 233 institutions attending 259 programs were 
queried via questionnaire at 6-mos. and 12-mos. post-program to evaluate 
quantitative and qualitative changes on clinical and economic outcomes due 
to modifications in their management of AHF. 
Results: Of the 93 and 122 institutions responding to the 6-mos. and 
12-mos. questionnaires, 79 (85%) and 113 (93%), respectively, changed 
Questionnaire 
Improvements: 6.mos. 12-mos. 
n I%: 95% Cl) n 1%: 95% Cl) 
~Clinical 
TEconomic 
@uality of Life 
~Hosp. readmit rate 
.tDRG 127cost 
, .  I  
21 (48%; 30-65) 39 (68%; 52-81) 
8 (16%; 7-34) 25 (44%: 29-59) 
21 (48%; 30-65) 48 (84%: 69-93) 
13 (30%; 15-47) 34 (60%; 43-74) 
7 I1 6%: 5-32) 14 125%: 1239) 
;ER visits 6 (14%: 4-29) 34 {60%; 43-743 
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their approach to treating AHF, and 44 (47%) and 57 (47%) were tracking 
outcomes. Analysis showed statistically significant improvements in clinical 
and economic outcomes that markedly improved over the I-yr period (table). 
Conclusions: 1) A novel educational program created as a forum in 
which health care professionals share their experiences in the management 
of AHF contributes positively to changes in institutional management guide- 
lines/protocols, and 2) implementing changes based on a multidisciplinary 
approach significantly improves outcomes over a I-yr period. 
POSTER 
112161 Efficiency in Cardiac Care 
Wednesday, March 15,2000,9:00 a.m.-l I:00 a.m. 
Anaheim Convention Center, Hall A 
Presentation Hour: 9:00 a.m.-IO:00 a.m. 
oratory time stamp. Operational costs were calculated as the sum of human 
resource costs plus reievant test c:osts at each clinic. 
Results: POC testing resulted in decreased TAT, narrower range of TAT, 
and positive reimbursement potential due to the face-to-face encounter be- 
tween patient and physician. 
Median TAT (range) 
Operational cost to clinic 
Potential reimbursement 
POC clinics 
8 min’ (4 to 22 min) 
5 7.69 
$21.75 
Control clinics 
498 min (22 min to 23) 
$1.10 
$0.00 
*p < 0.05 vs. control, Kruskal-Wallis 
Conclusion: POC PT/INR testing results in better quality of care through 
decreased TAT and provides added opportunity for education and decision 
support through face-to-face contact between the patient and the physi- 
cian/clinic staff. Despite increased operational costs, the reimbursement po- 
tential of POC testing is favorable to the physician. 
1216-l 3 An Emergency Department Chest Pain Center 1216-l 5 
Impacts the Disposition of All Patients With Acute 
Does Estimating Hospital Cost Require Detailed 
Chest Pain: A Two-Year Registry 
Departmental Costing, or are Whole Hospital 
Approaches Just as Good? 
Brian G. Abbott, Islam Abdel-Aziz, Edward P. Monica, Frans J. Th. Wackers. 
Yale University School of Medicine, New Haven, Connecticut, USA 
Steven D. Culler, William S. Weintraub, Debbie Canup, Stephanie Connolly, 
Edmund R. Becker. Emory Universifx Atlanta, CA, USA 
Background: Emergency Department (ED) Chest Pain Centers (CPC) have 
been shown to be both efficient and cost-effective in the triage of patients 
with acute chest pain in the ED. Few studies have examined the direct impact 
of a CPC on the overall disposition of all patients evaluated for chest pain in 
the ED, with and without acute diagnostic ECG changes. 
Background: Studies evaluating hospital cost have used one of two ap- 
proaches: 1) adjusting hospital charges using a single hospital wide cost-to- 
charge ratio; or 2) adjusting hospital charges using departmental cost-to- 
charge ratios. 
Methods: From July 1997 (institution of the Yale CPC) to June 1999, 
1,423 patients with acute chest pain and a normal or nondiagnostic ECG were 
evaluated in the Yale ED-CPC. A registry of the disposition of all ED patients 
with chest pain was collected at intervals from April 1995 to July 1999. In 
the CPC acute myocardial infarction (AMI) was ruled-out using serial cardiac 
enzymes, or immediate resting radionuclide myocardial perfusion imaging 
(MPI) during ongoing chest pain. Patients without AMI underwent either 
exercise EGG or dipyridamole/exercise MPI for inability to exercise/rest ECG 
abnormalities. 
Methods: This study examines the differences in average cost and the 
correlation coefficient between estimated costs using the two costing ap- 
proaches for patients undergoing coronary angioplasty at Emory University 
hospital between 1990 and 1998. Hospital charges by department and to- 
tal hospital charges were obtained for each patient from UB-92 statements 
prepared by the hospital’s finance department. The final data set contained 
19,380 patients. 
Results: 
Results: Of 1,423 patients enrolled in the CPC, 83% were discharged 
home and 17% were admitted. During a a-year period the overall pattern of 
admissions/discharges of patients with chest pain had changed substantially. 
Total hospital admissions (directly from ED and via CPC) had decreased from 
54% in 1997 to 45% in 1999. This reduction was largely due to a decrease 
in “rule-out-AMI” patients, from 32% to 18%. The number of admissions for 
AMI and unstable angina during the same time remained unchanged. 
All Patients 
WHOLE 
$7.554 
Stent Patient Only 
Emergency CABG 
Age 65-75 
Age > 75 
Males 
Females 
Previous MI 
Died During Hospitalization 
DEPT 
$6.847 
R’ 
0.977 
Disposition of Patients Presenting to the 
I 60 , 
Emergency Departmentwith Chest Pain 
/ 
$8,785 $8;202 0.979 
$24,966 $23,401 0.985 
$7,994 $7,245 0.983 
$8,283 $7,541 0.964 
$7,425 $6,738 0.979 
$7,887 $7,129 0.969 
$8,031 $7,260 0.981 
$21,371 $20,371 0.980 
f 40 
‘CPC - - Admitted to Hospital 
;P JULY 97 --Discharged Home 
30 
,995 Oct. 97 DBC. 97 May. 98 Sep. 9s Apr. 99 
Conclusion: The institution of a Chest Pain Center not only impacted the 
overall number of patients admitted and discharged, but it also affected the 
“patient-mix” by restricting hospital admission to more appropriate patients. 
1 1216-l 4 1 Comparison of Point-of-Care and Standard 
Reference Laboratory PT/INR Testing in Patients 
on Routine WarFarin Therapy: An Engineering 
Work Process Flow Study 
Franck R. Guilloteau, Paul M. Campbell, Charles R. Denham, Alan 
K. Jacobson. Premier lnnovafion Institute, Austin, TX; Loma Linda VA 
Medical Center, Loma Linda, CA, USA 
Background: To evaluate the work process flow and economic impact of 
point-of-care (POC) PT/INR testing in the physician office setting for patients 
on oral warfarin therapy. 
Methods: Prospective analysis of work process flow and retrospective 
analysis of operational costs were conducted in four clinics. Two clinics em- 
ployed POC testing with CoaguChek” (Roche Diagnostics) in the physician 
office. Two control clinics processed PT/INR results obtained from standard 
reference laboratories and reported results to patients via telephone. Total 
turnaround time (TAT) was defined as the time from initial blood draw to 
patient notification of test result. A Community Based Management Engineer 
mapped TAT at each clinic with a stopwatch or calculated TAT from the lab- 
Conclusions: While average estimated cost based on whole hospital 
cost-to-charge ratio is larger than average estimated cost based on depatt- 
ment cost-to-charge ratios, the correlation between the two estimates is over 
96% for all patient categories. These findings suggest that either method pro- 
vides similar estimates of hospital costs, with whole hospital cost-to-charge 
ratios offering a less expensive, easier to obtain estimate of cost, especially 
for clinical trials, when departmental details are not required. 
1 1216-l 6 ] Impact of a HCFA/Medicare Compliance Policy on 
Inpatient Cardiology Billing Practices and Faculty 
Productivity 
D. Douglas Miller, Chloe Getsey. Saint Louis University, St. Louis, MO, USA 
The U.S. Office of Inspector General (OIG) has issued guidelines for physi- 
cian billing in Medicare patients. Many academic health centers (AHC) have 
introduced institutional compliance programs to satisfy OIG and HCFA re- 
quirements. A high percentage (58.9%) of U.S. cardiovascular services are 
delivered to Medicare patients > 6.5 years old, but the impact of compliance 
initiatives on cardiologist billing practices & productivity has not been re- 
ported. Our faculty provide professional cardiac setvices (45% Medicare) to 
a 300 bed urban AHC in a midwest market with 26% managed care penetra- 
tion. Inpatient billing practices &faculty productivity, before (FY98) and after 
(FY99) the introduction of our AHC compliance program are summarized in 
the table. 
Visit level coding and HCFA billing compliance determinations of “un- 
billable” notes were performed by independent expert staff. The AHC and 
department provided monthly reports & education on billing and compliance 
performance to Cardiology managers and faculty in FY99. 
We conclude that implementation of a HCFA billing compliance program at 
the Cardiology divisional level enhances physician productivity and Medicare 
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# Total Hospital Admissions 
# Cardiology Inpatient Encounters 
# Cardiology faculty 
% HCFA “Unbillable” Visits 
N96 N99 
15,737 16,247 
9,474 11,271 
19 19 
Dept. of Internal Medicine 
Division of Cardiology 
% Initial Hospital Visits Billed at 
10.1 6.0’ 
15.3 9.3* 
vention study evaluated physicians’ ordering of CBC tests. In the intervention 
group, physicians were prompted to consider individual component tests 
versus CBC. The study analyzed 5,168 orders. In the intervention group, 
CBC ordering significantly decreased from 76% before prompting to 49% 
after implementation of intervention. Component ordering increased from 
26% to 51%, respectively (p = 0.001). Ordering patterns did not change in the 
control group. Computer-based informational prompts can modify physician 
medication prescribing and laboratory test ordering. 
Level I 
Level II 
Level Ill 
* = P < 0.05 “s FY98) 
57.3 29.3’ 
7.8 3.1 
35.0 57.6’ 
1505-Z Making Cardiac Databases More Clinically Useful 
by Combining “Roll Forward” Update Programming 
With Scanning Technology 
billing compliance for inpatient cardiovascular services, potentially reducing 
the institutional risk of exposure to an OIG audit. 
Richard E. Shaw, Michael B. Pliam, Nick Gawrit, Scott McLaughlin. San 
Francisco Heart Institute at Seton Medical Center; Daly City: California; 
SIWHeartBase, Chicago, Illinois; Optiform, Indianapolis, Indiana, USA 
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1505-l Computer-Based Informational Prompts Modify 
Physician Ordering 
Background: Although cardiac databases have become relatively common 
in hospital settings and are often used extensively for analysis and reporting 
of data, the full potential of utilizing these systems to support the ongoing 
process of patient care has yet to be realized. One important potential ap- 
plication of database technology is tapping the wealth of clinical information 
that is stored in the database on patients returning for repeat evaluation or 
further treatment. Physicians are typically faced with the challenge of re- 
capturing historical clinical and treatment data before beginning their current 
contact with the patient. No automated methods currently exist to summarize 
and display historical data in a format that can be used by the physician to 
facilitate the current contact as well as providing a means to get updated 
information back into the database. 
Clifton R. Lacy, Maureen Bueno, Evan Cadoff, Dong-Churl Suh, Joseph 
A. Barone, John B. Kostis. UMDNJ-Robert Wood Johnson Medical School; 
Robert Wood Johnson University Hospifa/, New Brunswick, NJ, USA 
We prospectively evaluated the impact of computer-based informational 
prompts on physicians’ medication prescribing and laboratory test ordering. 
In the first study, we assessed the effect of a computer-based informational 
prompt on physicians’ adherence to national treatment guidelines for left 
ventricular dysfunction (LVD). Prompts were triggered by the ordering of an 
echocardiogram or MUGA scan. Physicians at our institution were randomly 
assigned in blind fashion to an intervention group (computer message to 
consider prescribing ACE inhibitors [ACEI] for patients with LVD) or a control 
group (no computer message). We studied the first 100 consecutive patients 
who had computer orders for echocardiogram or MUGA scan. Of these pa- 
tients, 75% were already on ACEI, had contraindications to ACEI, or were not 
found to have LVD on testing. Of the ACEI-eligible patients with LVD, 92% 
were appropriately treated with ACEI in the intervention group, compared 
with 77% in the control group. Of the 20 physicians who treated eligible 
patients, 89% appropriately treated patients with ACEI in the intervention 
group, versus 73% in the control group. Although the intervention group had 
greater prescribing than control, the difference was not statistically signifi- 
cant due to the high level of prescribing across both groups. The second inter- 
Methods: An approach has been developed that combines a process 
called “roll forward” update programming with scanning technology. The 
model for applying these techniques is the generation of a current clinical 
presentation form for patients returning to the hospital who are already in 
the cardiac database. The clinical presentation form contains information 
typically found in an extensive history and physical, including assessment of 
cardiac risk factors, prior procedures, clinical lab tests and medications. When 
a patient returns who is in the database, a program is started for the patient 
that scans through the entire history of the patient, rolling forward all prior 
information stored from other hospitalizations and followup contacts with the 
patient. This program automatically produces a current clinical presentation 
form that is bar coded with the patients medical record identifier. A physician 
who is interviewing or treating the patient can use this scanable form as a 
way to have extensive background on the patient as well as a mechanism to 
update all aspects of the patient’s current status. When this form is updated, 
it can be scanned directly into the cardiac database and provide updated 
information that is complete and accurate. 
Results: This system has been successfully implemented and will be 
demonstrated. 
Conclusion: This approach provides a practical mechanism for a cardiac 
database to support the process of patient care as well as providing an 
automated way to continuously update patient data 
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